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Abstract
Background. The healthy worker eﬀect (HWE) is a source of bias in occupational 
studies of mortality among workers caused by use of comparative disease rates 
based on public data, which include mortality of unhealthy members of the public 
who are screened out of the workplace. For the US astronaut corp, the HWE is 
assumed to be strong due to the rigorous medical selection and surveillance. This 
investigation focused on the eﬀect of correcting for HWE on projected lifetime risk 
estimates for radiation-induced cancer mortality and incidence.
Methods. We performed radiation-induced cancer risk assessment using Poisson 
regression of cancer mortality and incidence rates among Hiroshima and Nagasaki 
atomic bomb survivors. Regression coeﬃcients were used for generating risk 
coeﬃcients for the excess absolute, transfer, and excess relative models. Excess 
lifetime risks (ELR) for radiation exposure and baseline lifetime risks (BLR) were 
adjusted for the HWE using standardized mortality ratios (SMR) for aviators and 
nuclear workers who were occupationally exposed to ionizing radiation. We also 
adjusted lifetime risks by cancer mortality misclassiﬁcation among atomic bomb 
survivors.15.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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all-cause hazard rate by the simulated quantiles of the all-cause SMR resulted in a 
mean diﬀerence (not percent diﬀerence) in ELR of 0.65% and mean diﬀerence of 
4% for mortality BLR, and mean change of 6.2% in BLR for incidence. The eﬀect 
of adjusting the excess (radiation-induced) cancer rate or baseline cancer hazard 
rate by simulated quantiles of cancer-speciﬁc SMRs resulted in a mean diﬀerence 
of −1.2% in the all-cancer mortality ELR and mean diﬀerence of −6.4% in the 
mortality BLR. Whereas for incidence, the eﬀect of adjusting by cancer-speciﬁc 
SMRs resulted in a mean change of −14.4% for the all-cancer BLR. Only cancer 
mortality risks were adjusted by simulated quantiles for misclassiﬁcation, and 
results indicate a mean change of 1.1% for all-cancer mortality ELR, while the 
mean change in the all-cancer PC was approximately 4% for males and 6% for 
females.
Conclusions. The typical life table approach for projecting lifetime risk of 
radiation-induced cancer mortality and incidence for astronauts and radiation 
workers can be improved by adjusting for HWE while simulating the uncertainty of 
input rates, input excess risk coeﬃcients, and bias correction factors during 
multiple Monte Carlo realizations of the life table.
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1. Introduction
Historically, US astronauts have been occupationally exposed to space radiation 
during low earth orbit (LEO) missions associated with the Mercury, Gemini, 
Apollo, Skylab, Shuttle, and International Space Station programs [1, 2]. The 
majority of exposure has been to low-energy geomagnetically-trapped protons 
residing in the South Atlantic Anomaly and to a lesser degree, relativistic 
high-energy ions, or galactic cosmic rays (GCR) [3, 4]. Greater exposure to GCR 
occurred during the cis-lunar transits during the Apollo program, when astronauts 
were not aﬀorded the protection of the Earth’s geomagnetic shielding [5]. The 
potential for exposure to high-energy protons generated during anomalously large 
solar particle events (ﬂares) is an additional hazard faced by crewmembers who 
will leave Earth’s geomagnetic shielding during interplanetary travel to Mars [6]. 
Additional information regarding space radiation exposure and research ﬁndings 
has been reported [7, 8, 9, 10].
Surveillance and mitigation of risks from space radiation exposure are key 
components of NASA’s Human Research Program (HRP) which consists of six 
elements: space radiation, human health counter-measures, exploration medical 
capability, space human factors and habitability, and behavioral health and 
performance [11]. These elements provide the HRP’s knowledge and capabilities to liyon.2015.e00048
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they advance the readiness levels of technology and countermeasures to the point 
where they can be transferred to the customer programs and organizations. NASA 
has employed lifetime risk projection for radiation-induced cancer risk since the 
late 1990s [12], and operationally employs lifetime risk projection for comparing 
each crewmember’s projected upper 95th percentile of radiation-induced cancer 
mortality risk against the 3% career limit prior to all missions [13, 14, 15, 16, 17]. 
Historical lifetime risk projections are also made for the entire space radiation 
exposure history archive, which includes previous space radiation exposures, 
medical radiation exposures, and research-based exposures such as the Apollo and 
Skylab era low-microCurie quantity ﬂight-based radiopharmaceutical experiments 
to establish total body water, red cell mass, and plasma volume [18, 19].
When projecting lifetime risk of radiation-induced cancer for astronauts, the 
healthy worker eﬀect (HWE) presents a unique challenge, since the cancer 
mortality rates and vital statistics used are derived from the general public – which 
are upwardly biased [66, 65]. Therefore, lifetime risk projection for healthy 
workers requires data that are more amenable for a healthy population – which are 
essentially non-existent. When compared with the general public, a healthy 
working population will have less chronic disease, longer survival, and may or may 
not have less cancer and cardiovascular disease, depending on the constellation of 
competing causes of death experienced by the cohort. Overall, a healthier working 
population would have a lower all-cause morbidity (mortality) rate, ultimately 
shifting events to occur later in life. The HWE, also known as the healthy hired 
eﬀect and healthy survivor eﬀect, is a bias that causes morbidity or mortality to be 
lower among workers when compared with the general population, because 
unhealthy individuals are screened from or leave the workplace [20, 21, 22]. The 
HWE may persist in a workforce if there are factors related to both the end of 
employment and morbidity (mortality). In manned space activities, astronaut 
medical selection screening is far more stringent than typical employee or aviator 
screening because of the physiological demands associated with microgravity and 
long-duration operations in a harsh working environment. As such, the HWE is 
likely to be much stronger among astronaut populations.
Several methods have been recommended for controlling for the HWE in 
occupational cohort studies [23]. The simplest way to minimize bias in modeled 
risks due to the HWE is to employ an internal control population which is 
preferentially unexposed, or at least minimally exposed. Partitioning the data for 
exposed and internal controls into discrete follow-up periods to control for past 
exposure and employment history is also beneﬁcial. This can be accomplished by 
adjusting modeled risks with either a continuously- or ordinally-scaled variable 
representing employment duration. Controlling for current employment status liyon.2015.e00048
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who leave work due to higher exposures and face a greater risk since they are no 
longer employed. Restricting an analysis to long-term survivors for which the 
HWE is believed to be minimal will also ﬁlter out employees with short work 
histories who have a greater propensity for mortality. Exposure can also be lagged 
so that it is only considered for the healthiest participants.
The standardized mortality ratio (SMR) is deﬁned as the ratio of observed to 
expected deaths for an occupational cohort, where the number of expected deaths is 
determined by applying age–gender–birth cohort-speciﬁc person-years of 
follow-up to the relevant national mortality rates for the same age, gender, and 
calendar period. SMRs are the most reliable metric for worker mortality when an 
internal control group of non-exposed employees is not available. Table 1 lists 
all-cause and cancer-speciﬁc SMRs for occupational mortality studies of pilots, 
aircrew, and nuclear workers in the nuclear fuel, nuclear power, and nuclear 
weapons industries – which are relevant occupations representing aviators and 
workers who are occupationally exposed to ionizing radiation. (Table 2 lists 
additional SMRs from a published meta-analysis of nuclear workers [46].) As can 
be noticed, the majority of SMRs are below unity, suggesting that the mortality 
experience of the workers studied was lower than the mortality experienced by the 
general public. The presence of elevated SMRs in a cohort study essentially implies 
a greater mortality rate in the workers, primarily because of a diﬀerence in the 
pattern of proportional mortality ratios within each population, as there is no 
reason to expect similarity between disease-speciﬁc proportional mortality ratios in 
a healthy working cohort and general population. The occupational hazards 
associated with this mixture of industries and professions in Table 1 collectively 
represent a similar hazard to which astronauts are exposed, namely, the risk of 
occupationally-related radiation-induced cancer mortality.
The least biased approach for minimizing HWE involves use of an internal 
control population against which the cancer incidence and mortality of exposed 
workers is compared. The Longitudinal Study of Astronaut Health (LSAH) makes 
use of such an internal control population, since it enrolls 
age–gender–BMI-matched controls for each newly selected astronaut. By 1993, the 
cancer standardized mortality ratio for astronauts was 0.47 (95% conﬁdence 
interval (CI): 0.1–1.05), which suggests that cancer mortality in the astronaut 
cohort is approximately half of that in the general population [47]. However, when 
comparing the astronaut cohort with the LSAH controls, cancer mortality was 
nearly 3.5 times greater [48], since the SMR was 3.45 (95% CI: 0.66–7.56). The 
most recent report [24] on cancer SMR in the LSAH for 1980–2009 still indicates 
much lower risk of cancer among astronauts (SMR = 0.47, 95% CI: 0.19–0.97) liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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Table 1. Standardized mortality ratios (SMR) for aviator and nuclear worker studies.
Type of Work Fem
alebreast
Prostate
Bladder
Kidney
CNS
Thyroid
Non-Hodgkin’s
Hodgkin’s
M
ultiplem
yelom
a
Leukem
ia
US Astronauts [24]
Aircrew [25] 1.23 0.74 0.77 1.14 1.06 0.66 0.67 1.14 0.91
Aircrew-female [26] 1.11 0.67 0.82 1.49 0.99
Aircrew-male [26] 1.09 1.59 0.94 2.28 1.32
Aircrew [27] 0.94 0.59 1.2 1.48 0.71 0.86 1.05
Aircrew [28] 1.52 1.22 1.42 0.62 0.86
Aircrew-female [29] 1.28 0.82 1.66 2.15 0.79
Aircrew-male [29] 2.41 0.78
Aircrew [30] 0.6
Aircrew [30] 0.27
Cockpit [31] 0.96 0.79 2.13 1.27 0.61
Cabin-female [31] 1.17 1.18 1.19 0.88
Cabin-male [31] 1.42 4.24 1.55
Cockpit-male [32] 1.26 0.52 0.49 1.68 1.6 0.68 0.69
Cockpit-male [33] 1 1.8 0.9
Nuclear fuels [34] 0.84 0.9 0.82 0.87 0.91 1.14 0.85 1.09 0.95 0.91
Nuclear fuels [35] 1.08 0.46 0.76 0.84 1.32 1.06 0.96
Nuclear power [36] 0.6 0.79 0.85 0.63 1.07
Nuclear power [37] 0.64 0.74 1.23
Nuclear power [38] 1.27 0.87 0.63 1.15 1.12 0.7 1.56 1.57 0.7
Nuclear power [39] 0.89 1 0.7 0.6 1.22 1.07 0.71 0.83 1.23
Nuclear power [40] 0.8 0.33 0.65 1.71 0.26
Nuclear weapons-no l 1.36 1.9 0.69 1.71 0.32 7.4 0.53 0.57 0.62 0.42
Nuclear weapons-10 y 1.51 2.23 0.7 2.39 0 11.05 0.9 0.5 0.97 0.38
Nuclear weapons [42] 1.01 0.87 0.85 1.08 0.62 0.9 0.97 0.56 1.15 0.77
Nuclear power/weapo 1.06 1.04 0.63 0.95 1.04 1.1
Nuclear weapons (OR 1 0.88 1.07 0.96 0.94 0.85 0.91
Nuclear weapons (SR 0.87 0.88 0.76 1.15 0.9 0.98 0.78 1.02
Nuclear weapons (HA 1.03 1.09 0.83 0.82 0.98 1.11 0.99 1.02 0.8
Nuclear weapons (ID 0.85 1.02 0.84 0.68 1.02 0.91 0.78 1.1
Nuclear weapons [44] 0.76 1.06 0.84 0.88 0.94 1.14 1.07 0.74 0.9
Chernobyl (nonexpos 1 0.82 0.77 1.08 0.67 0.9 1.14 0.84 1.2 0.76
Chernobyl (combined 1.03 1 1.02 1.08 0.51 0.9 0.58 0 1.06 0.8
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Allcancers
Buccalcavity
Esophagus
Stom
ach
Colon
Rectum
Liver
Pancreas
Respiratory
Larynx
Lung
Bone
M
elanom
a
Non-m
elanom
a
0.59 0.37
0.56 0.69 0.27 0.5 0.57 0.92 0.83 0.96 0.84 0.83 0.69 0.43 1.57 0.93
0.8 0.78 0.83 0.65 0.58 0.63 0.46 0.82 0.36
1.09 0.9 1.7 1.11 0.46 0.71 0.72 0.61 1.44 0.75 1.93 9.67
0.64 0.68 0.54 0.58 0.48 1.07 0.8 0.86 0.85 0.63 0.53 1.78
0.63 0.61 0.86 0.57 1.23 0.25 1.49
0.79 0.79 0.73 0.75 0.86 0.57
1.1 0.71 1.97 0.63 1.04 1.26 1.62 0.77
0.32 1.29
0.39 0.67
0.49 0.64 0.68 0.85 0.5 1.28 0.33 0.98
0.83 0.95 0.91 1.18 1.09 1.17 1.07
1.03 0.89 1.41 0.31 0.63 1.02 1.53 0.74
0.48 0.56 0.16 0.46 0.57 0.8 0.6 0.7 1.16 0.87 0.29 0.47
0.7 0.6 2.4 0.9 5.9 1.2 0.8 0.1 4
0.91 0.93 0.86 1 1.02 0.93 1.09 0.83 0.82 0.93 0.86 0.88 0.64 0.88 0.86
0.55 0.7 0.56 0.53 1.48 0.44 0.99 0.62 0.55
0.41 0.65 0.81 0.75 0.62 1.19
0.5 0.65 0.49 0.7 0.93 0.59
0.59 0.73 0.37 0.63 0.85 0.88 0.57 0.69 0.6 2.41
0.7 0.96 0.8 0.93 0.72 0.74
0.54 0.65 0.37 0.67 0.72 0.72 0.4 1.1 0.38 0.59
ag [41] 0.22 0.81 0.98 1.27 2.1 1.23 1.5 0.91 0.84 2.19
r lag [41] 0.31 1.03 1.01 0.92 2.09 1.37 1.24 0.92 0.84 1.36
0.9 0.97 0.1 0.6 0.91 0.92 0.96 0.92 0.63 0.91 0.39 1.11
ns [43] 0.99 0.98 1.03 1 0.98 0.95 0.99 0.98 0.96 0.98 0.99
NL) [44] 0.82 1.41 1.08 1.11 0.71 0.91 0.92 1.11
) [44] 0.51 0.75 0.69 0.84 0.63 0.84 0.5 0.67
N) [44] 0.64 0.78 0.77 0.88 0.85 0.94 0.41 0.82 0.62
S) [44] 0.74 0.57 0.59 0.86 0.65 0.91 0.43 0.88
0.49 0.69 0.77 0.71 0.63 0.87 0.58 0.67
ed) [45] 0.83 0.74 0.96 0.59 0.94 0.71 0.82 0.82 0.51 0.85 0 1.17
) [45] 1.06 1.48 1.45 0.6 0.85 1.33 1.28 1.12 0.92 1.05 1.1 0.95
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among nuclear workers [46].
Authors* Lung Larynx Esophagus CNS Kidney Bladder
Atkinson et al. 0.75 0.75 0.8 0.75 1.05
Beral et al. 0.75 0.3 0.65 0.7
Beral et al. 0.75 0.9 0.75 0.75 1.4 0.8
Boice et al. 1.1 2.75 1.25 0.8 1.4 0.7
Carpenter et al. 0.8 0.5 1.15 0.8 1.45 0.5
Checkoway et al. 1.3 0.8 1.75 1.2 0.7
Cragle et al. 0.75 0.5 0.4 0.45 1.9
Dupree-Ellis et al. 1.05 1.1 1.4 1.55 1.2 1.2
Dupree et al. 0.95 4.5
Fraser et al. 0.75 0.8 0.7 0.75 0.8
Loomis et al. 1.2 0.75 0.45 1.4 1.3 0.75
McGeoghegan et al. 0.8 0.75 0.75 0.6 0.55 0.85
McGeoghegan et al. 0.8 0.65 0.45 1.35 0.5 1.1
Pinkerton et al. 1.2 0.2 0.8
Ritz et al. 1 1.2 1.2 1.3 0.6 1.2
Ritz et al. 1.05 1.2 1.25 1.4 0.65 1.25
Ritz et al. 0.75 2 1.3 1.4 1.3 0.8
* See original publication [46] for citations for each author group listed.
when compared with the general population. When internal control populations are 
employed, the HWE may, nevertheless, still continue to operate.
This investigation explored methods to adjust for the HWE during projection of 
lifetime mortality and incidence risk of radiation-induced cancer for radiation 
workers in general. Risk coeﬃcients were modeled using data from the Life Span 
Study (LSS) of 120,000 Hiroshima and Nagasaki atomic bomb survivors [49, 50, 
51, 52], made available by the Radiation Eﬀects Research Foundation (RERF) [53]. 
Because the majority of exposures of LSS survivors involved exposure to prompt 
𝛾-rays and neutrons, lifetime risks generated in this study are not directly 
applicable to risks from particulate space radiation exposure because of diﬀerences 
in bioeﬀects of 𝛾 and neutron radiation and space radiation particles [4]. Additional 
consideration is required for assumptions regarding the radiation dose and 
dose-rate eﬀectiveness (DDREF) of various sources of ionizing radiation to which 
workers are exposed. Because of the complex mixture of particulate radiations in 
space with varying charge and energy, and the magnitude of analyses required for 
modeling risks from LSS survivors and correctly applying these risks during 
lifetime risk projection, we chose to limit our investigation to include generation of 
risk coeﬃcients and adjustment of lifetime risks by the HWE, cancer mortality 
misclassiﬁcation, DDREF, and the latency period after exposure. The following 
sections address Poisson regression to generate risk coeﬃcients, and life table 
calculations within a framework of Monte Carlo uncertainty analysis for the 
purpose of projecting lifetime mortality and incidence risks of radiation-induced 
cancer.liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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“zero-dose” population has baseline cancer rate 𝜆𝑐 . Ionizing radiation, a known carcinogen, elevates the 
baseline cancer rate by inducing an excess risk shown as 𝜆𝑟. The total risk to the exposed population 
becomes 𝜆𝑐+𝑟 (summation using 𝑐 + 𝑟 does not imply additive risk vs. multiplicative risk, but rather, 
implies risk is greater among the exposed). Poisson regression is used to determine the excess absolute 
risk 𝛽EAR, which is independent of the baseline cancer rate 𝜆𝑐 , as well as excess relative risk, 𝛽ERR, which 
is dependent on the baseline cancer rate. To minimize transfer bias from Japan to the US, the excess 
absolute risk 𝛽EAR (independent of the baseline rate in Japan) is added to the US cancer rate and divided 
by the US rate to give the relative risk (RR), from which one is subtracted to create a new excess relative 
risk for the US population, 𝛽ERR(EAR). Both 𝛽EAR and 𝛽ERR are speciﬁc to age at exposure 𝑎 and attained 
age 𝑡. Excess lifetime risk (ELR) is determined for the absolute model by multiplying together the life 
table survivorship function 𝑆(𝑡) and 𝛽EAR. ELR for the relative and transfer models multiply together 𝑆(𝑡), 
excess relative risk (𝛽ERR, 𝛽ERR(EAR)), and the baseline cancer rate, 𝜆𝑐(𝑡), from US vital statistics, since 
relative risks depend on the baseline cancer rate. Baseline lifetime risk (BLR) is based on the product of 
𝑆(𝑡) and 𝜆𝑐(𝑡).
2. Methods
2.1. Risk assessment – Poisson regression
This section describes how risk information needed for projection of lifetime 
risk of radiation-induced cancer mortality and cancer incidence was derived using 
Poisson regression of data obtained from the Radiation Eﬀect Research 
Foundations’s (RERF) Lifespan Study (LSS) of 120,000 Hiroshima and Nagasaki 
atomic bomb survivors [54, 55]. Projection of lifetime risk of radiation-induced 
cancer for worker populations or medically exposed populations is a common 
enterprise in the ﬁeld of radiation protection. Fig. 1 illustrates the framework of 
risk assessment and risk projection used in this investigation.
Deﬁnition of likelihood for Poisson rates. The rate of incidence or mortality, 
speciﬁc to age, gender, and other explanatory variables, is represented by models of 
two forms:
𝜆(𝑑, 𝑎, 𝑡, 𝐳) = 𝜆(𝑎, 𝑡, 𝐳) + 𝜖(𝑑, 𝑎, 𝑡), (1)liyon.2015.e00048
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by-nc-nd/4.0/).
Article No~e00048
8 http://dx.doi.org/10.1016/j.he
2405-8440/© 2015 The Authors. Pub
(http://creativecommons.org/licenses/or
𝜆(𝑑, 𝑎, 𝑡, 𝐳) = 𝜆(𝑎, 𝑡, 𝐳)[1 + 𝜌(𝑑, 𝑎, 𝑡)], (2)
or where 𝜆(𝑎, 𝑡, 𝐳) is the background rate at zero dose, 𝑑 is the dose equivalent in 
units of Sievert (Sv), 𝑎 is the age at exposure (years), 𝑡 is the attained age (years), 
𝜖(𝑑, 𝑎, 𝑡) is the excess absolute risk (EAR/104𝑛-Sv) for which 𝑛 is the person-years 
of follow-up, and 𝜌(𝑑, 𝑎, 𝑡) is the excess relative risk (ERR/Sv). The distinction 
between these equations is related to how excess risk is expressed, and not so much 
which representation is true. The models above establish the basis for grouped 
analysis, since 𝑑, 𝑎, 𝑡 are categorical variables derived from models for continuous 
variables by taking functions as piecewise constant on intervals. For survival data 
on individuals, the ﬁtted likelihood-based number of cases (deaths) in a group is 
expressed by the following Poisson regression model
𝑐(𝑑, 𝑎, 𝑡) ∼ 𝑃 [𝑛(𝑑, 𝑎, 𝑡)𝜆(𝑑, 𝑎, 𝑡, 𝐳)], (3)
where 𝜆(𝑑, 𝑎, 𝑡, 𝐳) can have either form above.
Fitting generalized models of Poisson rates. Generalized models of Poisson 
rates were ﬁtted in order to obtain dose-dependent excess absolute risk (EAR) and 
excess relative risk (ERR) coeﬃcients for lifetime risk projection. Let the 
gender-speciﬁc ﬁtted excess ERR or EAR rate for covariate group 𝑗 and dose group 
𝑘 be deﬁned as
?̂?𝑗𝑘 = 𝛽𝑘𝑥𝐷 exp{𝛽𝑎𝑥30 + 𝛽𝑡𝑥70}, (4)
where 𝑗 is a combination of age at exposure 𝑎 and attained age 𝑡, 𝛽𝑘 is the 
regression coeﬃcient for dose (Sv) group 𝑘, 𝑥30 = (𝑎 − 30)∕10 is the eﬀect 
modiﬁer for age at exposure 𝑎, 𝛽𝑎 is the regression coeﬃcient for age at exposure, 
𝑥70 = log(𝑡∕70) is the eﬀect modiﬁer for attained age 𝑡, and 𝛽𝑡 is the regression 
coeﬃcient for attained age.
Poisson regression. Regression coeﬃcients were derived using Poisson 
regression, for which the gradient update vector at each iteration was determined 
with the matrix cross-product
Δ?̂? = (𝐙T𝐖𝐙)−1𝐙T𝐖𝐲, (5)
where the data matrix elements
𝑧𝑗𝑘 = 𝑛𝑗𝑘
𝜕𝑔(𝐱∗
𝑗𝑘
; 𝜷∗)
∗ (6)𝜕𝜷
liyon.2015.e00048
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𝑗𝑘
; 𝜷∗), which 
was equal to ?̂?𝑗 + ?̂?𝑗𝑘 for EAR models and ?̂?𝑗[1 + ?̂?𝑗𝑘] for ERR models. The 
background rate is given in the form
?̂?𝑗 = exp{𝜷𝑇 ; 𝐱}, (7)
where 𝐱 = (1, 𝑥naga, 𝑥hiro∗nic, 𝑥naga∗nic, 𝑥30, 𝑥230, 𝑥70, 𝑥
2
70, I(𝑡 > 70)𝑥
2
70) and 𝑥hiro and 
𝑥naga are indicators for city, and 𝑥nic is an indicator for ground distance ≥ 3 km. 
For the leukemia incidence models for males and females 𝐱 =
(1, 𝑥naga, 𝑥bc, 𝑥2bc, 𝑥30, 𝑥
2
30, 𝑥70, 𝑥
2
70, 𝑥hiro∗nic, 𝑥naga∗nic), where bc = (yob −
1915)∕10 (bc is the birth cohort, and yob is the year of birth). The weights are 
deﬁned as
𝑤𝑗𝑘 = (𝑛𝑗𝑘𝑔(𝐱∗𝑗𝑘; 𝜷
∗))−1, (8)
and residuals deﬁned as
𝑦𝑗𝑘 = 𝑑𝑗𝑘 − 𝑛𝑗𝑘𝑔(𝐱∗𝑗𝑘; 𝜷
∗). (9)
Iterations started by setting the vector of regression coeﬃcients 𝜷 equal to small 
near-zero starting values. Successive iterations involved adding the gradient-based 
update vector to the most recent vector of coeﬃcients in the form
?̂?
(𝑡+1) = ?̂?(𝑡) +Δ?̂?, (10)
until convergence was reached when ‖Δ?̂?‖ < 10−4. In most cases, convergence 
was reached within 𝑇 = 50 iterations.
Poisson regression coeﬃcients and “risk coeﬃcients”. The results of a 
Poisson regression model are the ﬁtted coeﬃcients 𝛽𝑘 for radiation dose, 𝛽𝑎 for the 
age at exposure eﬀect modiﬁer, and 𝛽𝑡 for the attained age eﬀect modiﬁer for the 
speciﬁc model being ﬁt. There were only two models ﬁtted: excess absolute and 
excess relative risk, which are deﬁned in (1) and (2). When combining together the 
coeﬃcients in (4), the result is a function of the excess radiation-induced cancer 
risk which depends on radiation dose, age at exposure, and attained age. Recall, the 
generalized cancer rate, 𝑔(𝐱∗
𝑗𝑘
; 𝜷∗) in the LSS data is ﬁtted, and is equal to ?̂?𝑗 + ?̂?𝑗𝑘
for EAR models and ?̂?𝑗[1 + ?̂?𝑗𝑘] for ERR models. For the EAR model, the “risk 
coeﬃcient” (not regression coeﬃcient) is represented using the notation 𝜖(𝑑, 𝑎, 𝑡) =
?̂?𝑗𝑘 and for the ERR model, the notation is 𝜌(𝑑, 𝑎, 𝑡) = ?̂?𝑗𝑘. Putting together the 
previously deﬁned parameters, we have for the EAR model
𝑔(𝐱∗
𝑗𝑘
; 𝜷∗) = baseline risk + excess absolute risk
= ?̂?𝑗 + 𝜖(𝑑, 𝑎, 𝑡)
= ?̂?𝑗 + ?̂?𝑗𝑘
= exp{𝜷𝑇 ; 𝐱} + 𝛽𝑘𝑥𝐷 exp{𝛽𝑎𝑥30 + 𝛽𝑡𝑥70}, (11)liyon.2015.e00048
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𝑔(𝐱∗
𝑗𝑘
; 𝜷∗) = baseline risk × relative risk
= baseline risk × [1 + excess relative risk]
= ?̂?𝑗[1 + 𝜌(𝑑, 𝑎, 𝑡)]
= ?̂?𝑗[1 + ?̂?𝑗𝑘]
= exp{𝜷𝑇 ; 𝐱}
[
1 + 𝛽𝑘𝑥𝐷 exp{𝛽𝑎𝑥30 + 𝛽𝑡𝑥70}
]
. (12)
The resulting “risk coeﬃcient” for the EAR model is 𝜖(𝑑, 𝑎, 𝑡) = 𝛽𝑘𝑥𝐷 exp{𝛽𝑎𝑥30 +
𝛽𝑡𝑥70}. During lifetime risk projection, the regression coeﬃcients obtained from 
the ﬁtted EAR model (𝛽𝑘, 𝛽𝑎, 𝛽𝑡) are multiplied by input values of dose, age at 
exposure, and attained age to derive a function of EAR whose value changes with 
attained age. The input value for attained age is based on the speciﬁc row being 
considered of a 1-year complete life table (𝑡 = 1, 2, … , 100). For the ERR model, 
the risk coeﬃcient is 𝜌(𝑑, 𝑎, 𝑡) = 𝛽𝑘𝑥𝐷 exp{𝛽𝑎𝑥30 + 𝛽𝑡𝑥70}, which is determined 
using regression coeﬃcients obtained from the ﬁtted ERR model (𝛽𝑘, 𝛽𝑎, 𝛽𝑡), which 
are multiplied by input values of dose, age at exposure, and attained age to derive a 
function of ERR whose value changes with attained age. Recall, the EAR and ERR 
risk coeﬃcients are derived from the LSS data, which is based on Japanese data. 
Because the EAR model is independent of baseline cancer rates, it can be assumed 
that EAR coeﬃcients are less biased by baseline cancer rates of the population 
being studied. However, ERR risk coeﬃcients are a multiple of the baseline cancer 
rate among the LSS subjects, and therefore are assumed to be more biased when 
applying them to other populations. For this reason, we introduce (later) a third risk 
coeﬃcient called the “transfer” coeﬃcient, which is determined by combining the 
EAR coeﬃcient with cancer rates for the US population to generate a novel type of 
ERR coeﬃcient for the US population termed “ERR(EAR).”
Goodness-of-ﬁt and regression diagnostics. Record-speciﬁc values were 
generated for the log-likelihood, given as
𝑙𝑗𝑘 = 𝑑𝑗𝑘 log(𝑑𝑗𝑘∕𝑛𝑗𝑘) − 𝑑𝑗𝑘, (13)
the deviance residual:
𝑟𝐷 = 𝑑𝑗𝑘 log(𝑑𝑗𝑘∕𝑑𝑗𝑘) + (𝑑𝑗𝑘 − 𝑑𝑗𝑘), (14)
and Pearson residuals:
𝑟𝑃 = (𝑑𝑗𝑘 − 𝑑𝑗𝑘)2∕𝑑𝑗𝑘. (15)
Measures of model goodness-of-ﬁt (GOF) were based on the sums 
∑
𝑟𝐷, 
∑
𝑟𝑃 , 
which are both 𝜒2 distributed with 𝑛 − 𝑝 degrees-of-freedom (d.f.). Models were 
assumed to ﬁt if 
∑
𝑟𝐷 was less than the corresponding d.f., since 
∑
𝑟𝑃 is more liyon.2015.e00048
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identiﬁed by use of leverage residuals,
𝐇 = 𝐖1∕2𝐙(𝐙T𝐖𝐙)−1𝐙T𝐖1∕2, (16)
and the change in regression coeﬃcients for removal of any overly inﬂuential 
observation, known as DFBETAS in linear regression, were determined via
(Δ?̂?∗)−𝑗𝑘 = −(𝐙T𝐖𝐙)−1𝑧𝑗𝑘𝑦𝑗𝑘𝑤𝑗𝑘∕(1 − ℎ𝑗𝑘). (17)
Several multicollinearity measures [56] were used to evaluate the degree of 
between-predictor multicollinearity in each model, which are shown below:
𝑞1 =
√
(
∑𝑝
𝑗=1 𝜆
2
𝑗
) − 𝑝
𝑝(𝑝 − 1)
𝑞2 =
(
1 −
min{𝜆𝑗}
max{𝜆𝑗}
)𝑝+2
, (18)
𝑞3 = 1 −
𝑝∑𝑝
𝑗=1(1∕𝜆𝑗)
𝑞4 = 1 −
√|𝐑|, (19)
𝑞5 =
(max{𝜆𝑗}
𝑝
)3∕2
, 𝑞6 =
(
1 −
min{𝜆𝑗}
𝑝
)5
, (20)
𝑞7 =
𝑝∑
𝑗=1
1 − 1∕𝑟𝑗𝑗
𝑝
, (21)
where 𝜆1, 𝜆2, … , 𝜆𝑗, … , 𝜆𝑝 are eigenvalues of the correlation matrix 𝐑, and 𝑟𝑗𝑗 is 
the 𝑗th diagonal element of the matrix 𝐑−1.
Poisson regression input data. Cancer incidence and mortality rate data for 
LSS atomic bomb survivors were obtained from the RERF [54, 55]. During 
Poisson regression of ERR and EAR models, deviance and Pearson residuals were 
calculated, from which GOF was determined. Contour plots of deviance as a 
function of age at exposure, attained age, and dose for each covariate group (record) 
were generated and GOF was compared with model degrees of freedom (𝑛 − 𝑝). 
Leverage residuals were also compared with the criterion 2𝑝∕𝑛, and deletion 
residuals were compared against 2∕
√
𝑛. For each model, we also performed logistic 
regression of leverage-based outliers (yes/no) on background rate covariates for ?̂?𝑗 , 
in order to address the association between outliers and covariates.
2.2. Risk projection – lifetime risks from life tables
The lifetime mortality risk of multiple exposures to radiation is quantiﬁed by 
applying the risks from each age at exposure to the total force of mortality 
experienced over a lifetime. In one sense, we are applying radiation risk 
coeﬃcients obtained from the follow-up of a bona ﬁde exposed cohort to the 
survival of a theoretically exposed population whose mortality increases liyon.2015.e00048
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independently of baseline cancer rates (absolute projection model). The following 
sections explain succinctly the complexities involved in calculating the lifetime 
risks of radiation-induced cancer mortality.
2.2.1. Hazard functions for radiation-induced cancer
Assume a complete life table with 1-year age intervals (𝑡 = 1, 2, … , 100) with a 
hazard function, ℎ(𝑡), and survivorship function, 𝑆(𝑡), at each interval. The hazard 
function for each age interval under the excess absolute risk (EAR) model is based 
on the excess absolute risk coeﬃcient (deaths/104PY-Sv), 𝜖(𝑑, 𝑎, 𝑡), at age 𝑡 for 
exposure at age 𝑎 in the absence of baseline cancer rates, given in the form
ℎ𝑐(𝑑, 𝑎, 𝑡) = 𝜖(𝑑, 𝑎, 𝑡)
= 𝛽𝑘𝑥𝐷 exp{𝛽𝑎𝑥30 + 𝛽𝑡𝑥70}, (22)
where 𝑥𝐷 is a random quantile for radiation dose (Sv), 𝑥30 = (𝑎 − 30)∕10 for 
exposure at age 𝑎, and 𝑥70 = log(𝑡∕70) for attained age 𝑡.
The “transported” ERR(EAR) excess relative risk hazard function model applies 
the transported excess relative risk coeﬃcient, 𝜌(𝜖, 𝑑, 𝑎, 𝑡), to baseline cancer rates 
using the relationship
ℎ𝑐(𝑑, 𝑎, 𝑡) = 𝜌(𝜖, 𝑑, 𝑎, 𝑡)ℎ𝑐(𝑡), (23)
where the risk coeﬃcient is determined by applying Japanese LSS excess absolute 
risk coeﬃcients to the US life table to generate radiation-induced deaths, which are 
added to baseline cancer deaths among a US population, and divided by baseline 
cancer deaths to obtain an attained age-speciﬁc ERR risk coeﬃcient in the form
𝜌(𝜖, 𝑑, 𝑎, 𝑡) = RR − 1
=
[
baseline risk + excess absolute risk
baseline risk
]
− 1
=
[
ℎ𝑐(𝑡) + 𝜖(𝑑, 𝑎, 𝑡)
ℎ𝑐(𝑡)
]
− 1
=
[
ℎ𝑐(𝑡) + 𝛽𝑘𝑥𝐷 exp{𝛽𝑎𝑥30 + 𝛽𝑡𝑥70}
ℎ𝑐(𝑡)
]
− 1, (24)
where ℎ𝑐(𝑡) is the hazard rate for spontaneously occurring cancer at age 𝑡 generated 
with cubic splines using 5-year interval number of cancers divided by 105, and RR
is the relative risk. Any values of ERR(EAR) that were negative after subtracting 
unity were set to zero.
Finally, the hazard function for radiation-induced cancer at age 𝑡 from exposure 
at age 𝑎 for the excess relative risk (ERR) model is based on the product of the 
excess relative risk coeﬃcient, 𝜌(𝑑, 𝑎, 𝑡), and the baseline cancer rate given asliyon.2015.e00048
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= 𝛽𝑘𝑥𝐷 exp{𝛽𝑎𝑥30 + 𝛽𝑡𝑥70}ℎ𝑐(𝑡), (25)
where 𝜌(𝑑, 𝑎, 𝑡) is the excess relative risk at age 𝑡 for exposure at age 𝑎.
2.2.2. Life table
To begin life table calculations, we ﬁrst set the number at risk at the beginning 
of the interval starting at the age at exposure 𝑎 equal to 𝑙(𝑎) = 100,000, assuming a 
population of 100,000 are exposed. We recall that for a “double-decrement” life 
table [60] the conditional death probability, 𝑞(𝑡), in age interval (𝑡, 𝑡 + 1) due to the 
combination of death from all causes and deaths due to radiation-induced cancer is
𝑞(𝑡) =
2(ℎ(𝑡) + ℎ𝑐(𝑑, 𝑎, 𝑡))
2 + (ℎ(𝑡) + ℎ𝑐(𝑑, 𝑎, 𝑡))
, (26)
where ℎ(𝑡) is the age-speciﬁc central death rate due to all causes in the absence of 
exposure and ℎ𝑐(𝑑, 𝑎, 𝑡) is the age-speciﬁc central death rate for cancer due to 
radiation exposure (see the next section for notation regarding calculation of 𝑞(𝑡)
from central death rates used in national registries and longitudinal studies with 
rates based on cases/person-years). The conditional probability that an individual 
will not die in the interval (𝑡, 𝑡 + 1) is
𝑝(𝑡) = 1 − 𝑞(𝑡), (27)
and the number of expected cases (deaths) from all causes in the absence of 
exposure and radiation-induced cancer is
𝑐(𝑡) = 𝑞(𝑡)𝑙(𝑡), (28)
where 𝑙(𝑡) is the number of individuals alive at the beginning of interval (𝑡, 𝑡 + 1). 
The number of survivors of interval (𝑡, 𝑡 + 1) at risk at the beginning of the next 
interval is found recursively as
𝑙(𝑡) = 𝑙(𝑡 − 1) − 𝑐(𝑡 − 1), (29)
and the number of person-years in each interval (𝑡, 𝑡 + 1) is approximated by
𝐿(𝑡) = 𝑙(𝑡) − 1
2
𝑐(𝑡). (30)
The survivorship function [61, 62, 63, 64] or cumulative probability of surviving 
beyond each interval is estimated with the equation
𝑆(𝑡) = 𝑙(𝑡)∕𝑙(𝑎), (31)
which is used for estimating the lifetime risks of radiation-induced cancer in an 
exposed working population.liyon.2015.e00048
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Equation (26) is described in this section. Central death rates and cancer rates 𝜆(𝑡)
obtained from RERF [53], CDC Wonder [66], or the National Center for Health 
Statistics [65] are based on cases per population (person-years). Under this 
assumption, the rate in interval (𝑡, 𝑡 + 1) is deﬁned as 𝜆(𝑡) = 𝑑(𝑡)∕𝐿(𝑡), where 𝑑(𝑡)
is the number of deaths and 𝐿(𝑡) is the number of person-years that 𝑙(𝑡) subjects are 
expected to live in the interval. Central death rates make no assumption about a 
uniform death rate within the interval (𝑡, 𝑡 + 1), and therefore the number dying in 
the ﬁrst half of an interval is not equal to the number dying in the second half, since 
it is unknown. In complete (abridged) life tables, however, the instantaneous death 
rate is assumed to be uniform within each interval, and therefore the conditional 
probability of death 𝑞(𝑡) = 𝑑(𝑡)∕𝑙(𝑡) is used, where 𝑙(𝑡) is the number of subjects 
alive at exactly time 𝑡 at the beginning of the interval.
Let 𝑛𝑎𝑡 be the expected (average) number of years lived by an individual of age 𝑡
who dies in age interval (𝑡, 𝑡 + 𝑛), and let
𝑛𝑓𝑡 =
1
𝑛
𝑛𝑎𝑡 (32)
be the fraction of the last 𝑛 years lived in this interval. The total number of 
expected years lived in interval (𝑡, 𝑡 + 𝑛) by 𝑙𝑡 subjects of age 𝑡 over the years 𝑡 to 
𝑡 + 𝑛 is 𝑛𝐿𝑡, which is comprised of 𝑛 years for each 𝑙𝑡+𝑛 survivors and 𝑛𝑎𝑡𝑛𝑑𝑡
average years for individuals who die in (𝑡, 𝑡 + 𝑛), given as
𝑛𝐿𝑡 = 𝑛𝑙𝑡+𝑛 + 𝑛𝑎𝑡𝑛𝑑𝑡
= 𝑛
[
𝑙𝑡 − (1 − 𝑛𝑓𝑡)𝑛𝑑𝑡
]
. (33)
Solving for 𝑙𝑡, we get
𝑙𝑡 =
1
𝑛
[
𝑛𝐿𝑡 + 𝑛(1 − 𝑛𝑓𝑡)𝑛𝑑𝑡
]
. (34)
Rearranging the central death rate, we have 𝑛𝑑𝑡 = 𝑛𝐿𝑡𝑛𝜆𝑡, and upon substitution of 
the number of deaths into the conditional death probability, we obtain
𝑛𝑞𝑡 =
𝑛𝑑𝑡
𝑛𝑙𝑡
= 𝑛
𝑑𝑡
1
𝑛
[
𝑛𝐿𝑡 + 𝑛(1 − 𝑛𝑓𝑡)𝑛𝑑𝑡
]
= 𝑛
𝜆𝑡
1
𝑛
[
1 + 𝑛(1 − 𝑛𝑓𝑡)𝑛𝜆𝑡
] . (35)
By assuming a uniform distribution of the time of death over the interval (𝑡, 𝑡 + 𝑛), 
we get 𝑛𝑎𝑡 =
𝑛
, or 𝑓 = 1 . When 𝑛 = 1 year, we now have2 2
liyon.2015.e00048
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1 + 12𝜆(𝑡)
= 2𝜆(𝑡)
2 + 𝜆(𝑡)
, (36)
which is the necessary transformation when using central death rates (person-year 
based rates) in a complete (abridged) life table. The next two sections describe the 
method for obtaining lifetime risks.
Excess lifetime risk (ELR) of radiation-induced cancer. The conditional 
probability of death due to radiation-induced cancer is estimated using the formula
𝜋(𝑑, 𝑎, 𝑡) = ℎ𝑐(𝑑, 𝑎, 𝑡)𝑆(𝑡), (37)
where ℎ𝑐(𝑑, 𝑎, 𝑡) is the hazard function and 𝑆(𝑡) is the survivorship function for the 
exposed population. Over a lifetime, the unconditional probability of 
radiation-induced cancer mortality (excess lifetime risk, ELR) for the annual dose 
received at age 𝑎 is given as
ELR = 𝜋(𝑎, 𝑑) =
∫ 100
𝑡=𝑎 𝜋(𝑑, 𝑎, 𝑡)𝑑𝑡
DDREF
. (38)
The number of radiation-induced cancer deaths (per 105 exposed individuals) is 
𝜋(𝑎, 𝑑) × 105.
Baseline lifetime risk (BLR) of cancer. The lifetime risk of spontaneously 
occurring (baseline) cancer is determined for comparative purposes, especially 
when calculating the probability of causation. For baseline risks, a diﬀerent form of 
the conditional death probability in interval (𝑡, 𝑡 + 1) is used:
𝑞(𝑡) = 2ℎ(𝑡)
2 + ℎ(𝑡)
. (39)
The conditional probability of death due to spontaneously occurring cancer at age 𝑡
is estimated using the formula
𝜋(𝑡, 0) = ℎ𝑐(𝑡)𝑆(𝑡), (40)
where ℎ𝑐(𝑡) is the hazard function for spontaneous cancer and 𝑆(𝑡) is the 
survivorship function determined when Eq. (39) is used for all life table 
calculations. The unconditional probability of spontaneously occurring cancer in 
the comparison nonexposed population over a lifetime (baseline lifetime risk, BLR) 
beginning at age 𝑎 is
BLR = 𝜋(𝑎, 0) = ∫
100
𝜋(𝑡, 0)𝑑𝑡. (41)
𝑡=𝑎
liyon.2015.e00048
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Probability of causation. Sometimes it is useful to determine the attributable 
risk caused by one or more radiation exposures. In principle, the attributable risk or 
probability of causation (PC) is deﬁned as the fraction of radiation-induced cancer 
deaths out of the total cancer deaths in an exposed population. Using the lifetime 
risks of radiation-induced cancer explained earlier, the lifetime PC is calculated 
with the equation
PC =
𝜋(𝑎, 𝑑)∕𝜋(𝑎, 0)
1 + (𝜋(𝑎, 𝑑)∕𝜋(𝑎, 0))
. (42)
2.2.3. Correction factors
Correction factor for the healthy worker eﬀect. This section describes 
empirical cumulative distribution ﬁtting (ECDF) of SMRs in order to obtain 
smooth pdfs, which were employed during simulation. Particle swarm optimization 
(PSO) was employed for ECDF of SMR values in columns of Tables 1 and 2 [57, 
58]. For each set of SMR values in each column of Table 1, SMRs were sorted in 
ascending order and their percentiles determined, which were assumed to represent 
ecdf values in the range [0, 1]. ECDF was performed using a variety of probability 
distributions including beta, normal, log-normal, chi-squared, gamma, F-ratio, 
Rayleigh, power, logistic, Laplace, and triangle. Let the position (solution) vector 
for chromosome (particle) 𝑙 be 𝐫𝑙(𝑡) = (𝑟1𝑙, 𝑟2𝑙, … , 𝑟pl) and velocity vector for 
chromosome 𝑙 be 𝐯𝑙(𝑡) = (𝑣1𝑙, 𝑣2𝑙, … , 𝑣pl), where 𝑝 is the number of parameters. 
The majority of the cdfs ﬁtted had two parameters (𝑝 = 2): location, 𝑎, and scale, 𝑏.
In addition, let 𝐛𝑙 = 𝐩𝑙(𝑡) be the best chromosome-speciﬁc solution vector ever 
observed throughout all generations, and let 𝐛𝑔 = 𝐩𝑙(𝑡) be the best solution vector 
ever observed throughout all generations. Initialize the position vector elements for 
all chromosomes with random uniform variates 𝑈 (0, 1), and set the velocity vector 
elements for all chromosomes to zero. The velocity update for each chromosome is
𝐯𝑙(𝑡 + 1) = 𝑤𝐯𝑙(𝑡) + 𝑐1𝑈 (0, 1)⊗ (𝐛𝑙 − 𝐫𝑙(𝑡)) + 𝑐2𝑈 (0, 1)⊗ (𝐛𝑔 − 𝐫𝑙(𝑡)), (43)
where 𝑤 is the inertia factor, 𝑐1 is the cognitive parameter and 𝑐2 is the social 
parameter, 𝐛𝑙 is the best historical ﬁtness for chromosome 𝑙, and 𝐛𝑔 is the global 
best chromosome. The inertia at iteration 𝑡 is 𝑤(𝑡) = 𝑤start − (𝑤start −𝑤end)𝑡∕𝑇max. 
After updating 𝐯𝑙(𝑡) for each chromosome, the chromosome solution vector update 
is 𝐫𝑙(𝑡 + 1) = 𝐫𝑙(𝑡) + 𝐯𝑙(𝑡 + 1). Parameter values for PSO were set to: 
#chromosomes = 50, 𝑣min = −0.05, 𝑣max = 0.05, 𝑐1 = 2, 𝑐2 = 2, 𝑤min = 0.4, and 
𝑤max = 0.9. A total of 𝑇max = 200 generations were used for ﬁtness calculations. liyon.2015.e00048
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distributions of SMRs.
Distribution CDF
Beta 𝐹 (𝑥) = 𝐼𝑥 (𝑎, 𝑏) (Incomplete beta)
Chi-squared 𝐹 (𝑥) =
Γ( 𝜈2 ,
𝜒2
2 )
Γ( 𝜈2 )
(Incomplete gamma)
F-ratio 𝐹 (𝑥) = 1 − 𝐼𝑥
(
𝜔
2 ,
𝜈
2
)
𝑥 = 𝜔∕(𝜔 + 𝑥𝜈) (Incomplete beta)
Gamma (Erlang) 𝐹 (𝑥) = 1 − exp(−𝑥∕𝑏)
[∑𝑐−1
𝑖=0
(𝑥∕𝑏)𝑖
𝑖!
]
Laplace 𝐹 (𝑥) =
⎧⎪⎨⎪⎩
1
2 exp(−(𝑥 − 𝑎)∕𝑏) if 𝑥 < 𝑎
1 − 12 exp(−(𝑥 − 𝑎)∕𝑏) if 𝑥 ≥ 𝑎
Logistic 𝐹 (𝑥) = 1 − 1∕(1 + exp((𝑥 − 𝑎)∕𝑏))
Log-normal 𝐹 (𝑥) = 12
[
1 + erf
(
log(𝑥)−𝜇
𝜎
√
2
)]
Normal 𝐹 (𝑥) = 12
[
1 + erf
(
𝑥−𝜇
𝜎
√
2
)]
Rayleigh 𝐹 (𝑥) = 1 − exp(−𝑥2∕(2𝑏2))
Student’s 𝑡 𝐹 (𝑥) = 1 − 𝐼𝑥
(
𝜈
2 ,
1
2
)
𝑥 = 𝜈∕(𝜈 + 𝑡2) (Incomplete beta)
Triangle 𝐹 (𝑥) =
{ (𝑥 − 𝑎)2∕(𝑏 − 𝑎)(𝑐 − 𝑎) if 𝑥 ≥ 𝑎, 𝑥 ≤ 𝑐
= (𝑏 − 𝑥)2∕(𝑏 − 𝑎)(𝑏 − 𝑐) if 𝑥 ≥ 𝑐, 𝑥 ≤ 𝑏
ECDF function approximation was based on each chromosome’s solution vector 
(location and scale) and ﬁtness was determined as 1∕MSE for chromosome 𝑙, 
where MSE is
MSE𝑙 =
1
2
𝑛∑
𝑖=1
(𝐹𝑖𝑙 − 𝐹𝑖)2, (44)
where 𝑛 is the number of SMR values for the cancer considered, 𝐹𝑖𝑙 is the predicted 
cdf value for the 𝑖th SMR value based on chromosome 𝑙’s current location and scale 
values, and 𝐹𝑖 is the observed ecdf value for the corresponding 𝑖th SMR value. In 
other words, 𝐹 was approximated using the individual SMRs as the x-value in the 
form 𝐹 (𝑥, location, scale), where location and scale were the relevant 
chromosome’s solution vector. Fitness was summed over the SMR samples during 
each generation. The probability distribution with chromosomes presenting the 
greatest global ﬁtness value was taken as the best-ﬁtting distribution, where 
location and scale were based on the global best solution, 𝐛𝑔. Descriptions of the 
various cdfs evaluated are listed in Table 3.
Once the best ﬁtting distribution was determined for each ﬁt, the parameters of 
the speciﬁc distribution were used for simulation of quantiles from the given 
distribution (see Monte Carlo section).liyon.2015.e00048
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Conﬁrmation and detection rates for various cancers were obtained from RERF 
Pathology report 4, which summarizes statistics acquired from the RERF Autopsy 
Program [59]. Cause of death among autopsied LSS survivors were compared with 
underlying cause of death on death certiﬁcates identiﬁed at the survivors’ local 
koseki seido (household registration system). The cancer conﬁrmation rate, 𝜃, is 
equal to the number of cases with agreement between death certiﬁcate and autopsy, 
divided by the number of death certiﬁcates with the given cancer listed as the 
underlying cause of death. Whereas the detection rate, 𝜙, was the number of cases 
with agreement divided by the number of autopsy cases for the given cancer. Let 𝑝
represent either rate, 𝑞 = 1 − 𝑝, and 𝑛 the number of cases in agreement. The 
standard error of each rate was then taken as 
√
𝑝𝑞∕𝑛. We determined the degree of 
misclassiﬁcation as the ratio 𝜓 = 𝜃∕𝜙, which is greater than one if the cancer was 
under-reported, and less than one if the cancer was over-reported. The quadrature 
sum of error of the ratio formed the standard error of the rate, that is, 𝜎𝜓 =√
𝜎2
𝜃
+ 𝜎2
𝜙
. We assumed that the correction factors were normally distributed with 
mean 𝜓 and standard deviation 𝜎𝜓 , and these parameters were used for simulation 
of quantiles for the assumed distributions during Monte Carlo analyses (see next 
section). Recall, correction factors 𝜓 are only applied to radiation-induced ELR for 
cancer mortality, since they are representative of mortality statistics for the LSS 
data.
2.2.4. Monte Carlo uncertainty analysis of lifetime risks
A commonly used approach for using Monte Carlo simulation to determine 
uncertainty in lifetime risks is to input ﬁxed values of Poisson regression 
coeﬃcients, ﬁxed values of dose, ﬁxed values of age-speciﬁc all-cause death rates, 
and ﬁxed value of age-speciﬁc cancer rates directly into life tables, along with 
uncertainty distributions for transfer of risk, dosimetry error, etc (see Fig. 2). The 
current approach used in this investigation simulates the uncertainty in the 
distributions of all input data, and applies randomly drawn quantiles from each 
distribution into a life table. In the commonly used approach, the uncertainty 
distributions are independent of life table input data, which allows investigators to 
multiply life table results (lifetime risks) by random quantiles from uncertainty 
distributions in order to obtain uncertainty in lifetime risk. However, under the 
current approach, the uncertainty data are heavily based on life table inputs and 
since the survivorship function is recursively derived, the uncertainty simulations 
need to be performed before each life table is calculated.
Simulating uncertainty in age-speciﬁc all-cause death rates. Random 
quantiles for the number of cases (deaths) 𝑐(𝑡) (𝑡 = 1, 2, … , 100) in each 1-year liyon.2015.e00048
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that in the common approach, the uncertainty in lifetime risks (life table results) are derived from 
application of uncertainty distributions for latency, dosimetry error, and transfer of risk from Japan to 
the US directly to lifetime risks form the life table. However, in the current investigation, each life table 
calculation is based on random quantiles drawn from the distribution of each life table input. BLR and 
ELR represent baseline lifetime risk and excess lifetime risk.
interval of the US life table [65] were obtained by use of a normal approximation to 
a binomial proportion, 𝐵(𝑛, 𝑝), where
𝜇 = 𝑛𝑝
= 𝐿(𝑡) 𝑐(𝑡)
𝐿(𝑡)
= 𝑐(𝑡) (45)
and
𝜎 =
√
𝑛𝑝𝑞
=
√
𝐿(𝑡) 𝑐(𝑡)
𝐿(𝑡)
(
1 − 𝑐(𝑡)
𝐿(𝑡)
)
=
√
𝑐(𝑡)
(
1 − 𝑐(𝑡)
𝐿(𝑡)
)
, (46)
and 𝐿(𝑡) is the number of person-years for age interval 𝑡. As long as min(𝑛𝑝, 𝑛𝑞) >
10, we simulated the number of deaths 𝑐(𝑡) with a normal approximation of the 
binomial as
𝑥𝑐(𝑡) ∼ 𝑁(𝑐(𝑡),
√
𝑐(𝑡)(1 − 𝑐(𝑡)∕𝐿(𝑡))). (47)liyon.2015.e00048
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binomially distributed quantile for death that is 𝐵(𝑛, 𝑝). In order to generate the 
simulated life table with deaths 𝑥
(𝑏)
𝑐 (𝑡) in each interval 𝑡, however, we must use two 
life tables. The ﬁrst life table provides the 𝜇 = 𝑐(𝑡) and standard deviation 𝜎 =
(𝑐(𝑡)(1 − (𝑐(𝑡)∕𝐿(𝑡))))1∕2 from the observed data with which we generate the 
pseudo-random quantiles 𝑥
(𝑏)
𝑐 (𝑡). The second life table recursively keeps track of 
the simulated number at risk in each 𝑡 + 1th interval by subtracting 𝑥(𝑏)𝑐 (𝑡) from 
𝐿(𝑡). The simulated quantile at each iteration for the hazard rate of all-cause deaths 
is determined from the simulated life table with the form
𝑥
(𝑏)
𝜆
(𝑡) =
𝑥
(𝑏)
𝑐 (𝑡)
𝐿(𝑡)
(48)
which is used later during generation of survivorship functions.
Simulating uncertainty in the baseline cancer mortality and incidence rates.
We simulated uncertainty in baseline cancer rates obtained from CDC 
WONDER [66]. Let 𝑐(𝑘) be the number of cases in each 5-year age category (𝑘 =
2, 7, … , 97), and let 𝐿(𝑘) = 100,000 be the total number of person-years at risk in 
each 5-year age category. To simulate the uncertainty in 𝑐(𝑘), we use the normal 
approximation to a binomial proportion, 𝐵(𝑛, 𝑝), where
𝜇 = 𝑛𝑝
= 𝐿(𝑘) 𝑐(𝑘)
𝐿(𝑘)
= 𝑐(𝑘) (49)
and
𝜎 =
√
𝑛𝑝𝑞
=
√
𝐿(𝑘) 𝑐(𝑘)
𝐿(𝑘)
(
1 − 𝑐(𝑘)
𝐿(𝑘)
)
=
√
𝑐(𝑘)
(
1 − 𝑐(𝑘)
𝐿(𝑘)
)
. (50)
Again, as long as min(𝑛𝑝, 𝑛𝑞) > 10, we simulated the number of cases 𝑐(𝑘) with a 
normal approximation of the binomial as
𝑥(𝑏)
𝑐
(𝑘) ∼ 𝑁(𝑐(𝑘),
√
𝑐(𝑘)(1 − 𝑐(𝑘)∕𝐿(𝑘))). (51)
If min(𝑛𝑝, 𝑛𝑞) ≤ 10 then the geometric distribution method was used to generate a 
binomially distributed quantile for cases that is 𝐵(𝑛, 𝑝). If 𝑝 < 0.1 and 𝑛𝑝 < 10, 
then 𝑃 (𝜆) is used to approximate 𝐵(𝑛, 𝑝), using mean 𝜆 = 𝑛𝑝. Random quantiles for 
the number of cases in each 5-year age group were then input into cubic splines to 
interpolate the number of cases for each 1-year age interval from 1 to 100. After liyon.2015.e00048
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is based on
𝑥
(𝑏)
𝜆,𝑐
(𝑡) =
𝑥𝑐(𝑡)
100,000
. (52)
Simulating uncertainty in radiation dose, risk coeﬃcients, latency period, and 
dose and dose rate eﬀectiveness. We also simulated random quantiles for 
radiation dose for exposure at age 𝑎 using a normal distribution with mean 1 Sv and 
standard deviation 0.1 Sv, that is 𝑁(1, 0.1). Correlated random quantiles of the 
regression coeﬃcients 𝛽𝑘, 𝛽𝑎, and 𝛽𝑡 were also generated as
(𝛽𝑘, 𝛽𝑎, 𝛽𝑡)𝑇 = 𝐕(𝜷)1∕2𝐳 + 𝜷, (53)
where 𝐕(𝜷)1∕2 is the square root matrix of the variance-covariance matrix for 
regression coeﬃcients from the EAR or ERR Poisson regression model, 𝐳 is a 
random vector of standard normal variates, and 𝜷 are the point estimates of ﬁtted 
Poisson regression coeﬃcients. The resulting correlated random quantiles for 
regression coeﬃcients (𝛽𝑘, 𝛽𝑎, 𝛽𝑡)𝑇 were combined with values for 𝑥𝐷, 𝑥30, and 𝑥70
for each row in the life table to determine the risk coeﬃcient 𝜆𝑗𝑘 (Eq. (4)).
The latency period, which is a lagged period when risks are gradually phased in, 
was simulated as
𝑥(𝑡)(𝑏)latency =
1
1 + exp(− 𝛿𝑡−𝜇
𝑠
)
, (54)
where 𝛿𝑡 is the time since exposure at age 𝑎, 𝜇 is a random variate from the triangle 
distribution TRI(5, 7.5, 20) for solid cancers and TRI(2, 2.25, 2.5) for leukemia, and 
𝑆 is a shape parameter that enforces risks to be phased in from 0.1 to 0.99 from 4 to 
11 years post exposure for solid cancers and from 0.4 to 4.1 years for leukemia [67].
Exposure scenarios. We simulated radiation exposures to 1 Sv for males and 
females (all races) at ages of 35, 45, or 55 and projected lifetime risks (excess and 
baseline) using 10,000 life tables with all possible combinations of adjustments by 
all-cause SMRs (mortality and incidence), cancer-speciﬁc SMRs (mortality and 
incidence), and correction for misclassiﬁcation (mortality). Most lifetime risk 
projection studies for radiation-induced cancer report results in units of risk/Sv or 
%/Sv, so we used a dose of 1 Sv. This was also not a dosimetry investigation or 
study to project lifetime risks based on radiation doses for historical or planned 
missions. Outputs for the median and 5th and 95th percentiles of ELR, PC, and 
BLR are provided for the EAR, ERR(EAR), and ERR models as well as a mixture 
model (“MIX”) where all 30,000 quantiles from EAR, ERR(EAR), and ERR 
models were combined, sorted in ascending order, and listed in the form of the liyon.2015.e00048
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Multiple linear regression analysis was performed for each cancer site for which we 
regressed ELRs, PCs, or BLRs, on age at exposure (35,45,55), and dummy 
indicators for applying all-cause SMRs, cancer-speciﬁc SMRs, misclassiﬁcation, 
and female gender. We multiplied the linear regression coeﬃcient for age at 
exposure by 10, to reﬂect the mean change in each dependent variable for a 10-year 
increase in age at exposure. The regression coeﬃcients are reported in the results 
along with their z-scores reﬂecting signiﬁcance (i.e., 𝛽𝑗∕𝑠.𝑒.(𝛽𝑗)).
Monte Carlo simulation of life table inputs. We employed 𝐵 = 10,000 Monte 
Carlo iterations for uncertainty estimation. At each 𝑏th iteration, random quantiles 
of all-cause death rates and cancer rates were generated for each 1-year age interval 
in the life table. When random quantiles for all-cause SMRs were applied to adjust 
for the all-cause HWE, 𝑥
(𝑏)
smrac, a single quantile was multiplied by all of the random 
quantiles for age-speciﬁc all-cause death rates, 𝑥
(𝑏)
𝜆
(𝑡). When projecting BLR, 
a single random quantile for each cancer-speciﬁc SMR, 𝑥
(𝑏)
smrca, was multiplied by 
each age-speciﬁc cancer rate, 𝑥
(𝑏)
𝜆,𝑐
(𝑡), during integration to obtain BLR. The entire 
life table calculation resulted in a subjective realization for baseline lifetime risk, 
𝑥
(𝑏)
BLR. When projecting ELR, random quantiles for cancer-speciﬁc SMRs, 𝑥
(𝑏)
smrca, 
age-speciﬁc latency, 𝑥(𝑡)(𝑏)latency, and correction for cancer misclassiﬁcation, 𝑥
(𝑏)
𝜓 , 
were directly multiplied by the radiation-induced cancer hazard function, 
ℎ𝑐(𝑑, 𝑎, 𝑡). Since the EAR model does not use baseline cancer rates, adjustment for 
cancer-speciﬁc SMRs and cancer misclassiﬁcation must be applied to the 
radiation-induced hazard function ℎ𝑐(𝑑, 𝑎, 𝑡) in order to aﬀect radiation-induced 
cancer risk. As such, we employed this approach for all excess cancer risk models 
(EAR, ERR(EAR), and ERR). The entire life table calculation resulted in a 
subjective realization for lifetime risk from radiation exposure, 𝑥
(𝑏)
rsk, which was 
divided by the random quantile for DDREF, 𝑥
(𝑏)
ddref (distributed LN(1.5, 1.35)) in the 
form
𝑥
(𝑏)
ELR = 𝑥
(𝑏)
rsk∕𝑥
(𝑏)
ddref . (55)
The quantile for the PC was obtained using the relationship
𝑥
(𝑏)
PC =
𝑥
(𝑏)
ELR∕𝑥
(𝑏)
BLR
1 +
(
𝑥
(𝑏)
ELR∕𝑥
(𝑏)
BLR
) . (56)
Median values and 5th and 95th percentiles were obtained for 𝑥
(𝑏)
BLR, 𝑥
(𝑏)
ELR, and 𝑥
(𝑏)
PC. 
Fig. 3 lists the computational workﬂow used for 𝐵 = 10,000 life table calculations 
for age at exposure- and gender-organ-speciﬁc BLR, ELR, and PC.liyon.2015.e00048
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3. Results
Results from Poisson regression were not the primary outcome of this 
investigation, and therefore, the ﬁtted EAR and ERR Poisson regression 
coeﬃcients for cancer mortality among male and female LSS survivors are listed in 
Supplementary material Tables S1–S4. The Fitted EAR and ERR regression 
coeﬃcients for cancer incidence for LSS males and females are listed in 
Supplementary material Tables S5–S8. The majority of Poisson regression models liyon.2015.e00048
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than 10,000 records used for each run. We did compare EAR and EAR regression 
coeﬃcients with cancer mortality and incidence results published by RERF 
investigators [54, 55] when a 4-parameter model including a gender eﬀect was run, 
and the results for coeﬃcients and deviance degrees of freedom were almost 
identical. However, we ran 3-parameter gender-speciﬁc models to derive 
coeﬃcients for this investigation, because we believed that the smaller 
gender-speciﬁc models would provide better ﬁts. All of the models that were ﬁt 
using Poisson regression had statistically signiﬁcant goodness-of-ﬁt results because 
their deviance was much lower than the model degrees of freedom (see 
Supplementary material). A voluminous amount of regression diagnostics was 
performed to identify outliers using standardized residuals, leverages, and 
DFBETAS, and these are provided in the Supplementary material. The level of 
work required to fully evaluate the regression diagnostics will be greater than the 
eﬀort used to present results in this report, and therefore additional interpretation 
will be needed. Nevertheless, these results are provided for the reader in the 
Supplementary material tables.
In the following tables and ﬁgures, we present results of ECDF of SMRs, and 
Monte Carlo uncertainty analysis of all-cause and cancer-speciﬁc SMRs. Fig. 4
illustrates 10,000 simulated quantiles for cancer-speciﬁc SMRs. Regarding ECDF 
of SMR values, the best ﬁtting distributions for SMRs were log-normal, logistic, 
and gamma (Table 4). The simulated realizations of all-cause SMRs resulted in an 
eﬀective multiple for the all-cause mortality rate in the life table, ℎ(𝑡), which 
reduced the number of deaths thereby prolonging survival – which represents the 
survival experience of a more healthy population.
Fig. 5 shows histograms for 10,000 quantiles of misclassiﬁcation correction 
factors, 𝜓 . Cancer conﬁrmation rates for death certiﬁcate agreement with autopsy
ﬁndings among LSS survivors in the LSS Autopsy Program are listed in Table 5. 
During the RERF Autopsy Program, autopsies were performed on 4920 (31%) of 
the 15,929 LSS survivors between January 1961 and December 1975. Results 
indicate that when compared with autopsy ﬁndings, underlying cause of death for 
most cancers was under-reported. Death certiﬁcate-based mortality for all cancers 
was under-reported by 37.6%, and prostate and bladder cancer was under-reported 
by 56.9%. Cancers of the liver, gallbladder, and cervix were under-reported via 
death certiﬁcates by approximately 300%. The only cancers that were found to be 
over-reported on death certiﬁcates were oral cavity (10.5%), lung (10%), and 
leukemia (4.8%). Only cancer mortality risks were adjusted by simulated quantiles 
for misclassiﬁcation, and results indicate the all-cancer mortality ELR mean 
diﬀerence was 1.1%, while the mean change in all-cancer PC was approximately 
4% for males and 6% for females.liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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The concept of correcting lifetime risks by the HWE is shown in Fig. 6, which 
illustrates the survivorship function, 𝑆(𝑡), with and without multiplying the 
underlying all-cause death rate, ℎ(𝑡), by the all-cause SMR. Results shown in Fig. 6
represent the life table survivorship function 𝑆(𝑡) and nonleukemia male incidence 
rate, ℎ𝑐(𝑡), required for determination of BLR for a US male population of 100,000 
exposed to radiation at age 35. Values of 𝑆(𝑡) at attained age 𝑡 = 100 without and 
with correction for HWE (i.e., ℎ(𝑡) = ℎ(𝑡)SMR) were 𝑆(100) = 0.016 and 𝑆(100) =
0.288, respectively. The integral product ∫ 𝑆(𝑡)ℎ𝑐(𝑡)𝑑𝑡 based on the rate ℎ𝑐(𝑡) for 
nonleukemia was 0.526 without HWE correction and 0.816 with correction for liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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the normal approximation to the binomial distribution.
HWE. Therefore, the mean change in BLR for nonleukemia was 0.29 =
0.816–0.526. This was expected, because a worker cohort whose all-cause SMR is 
less than one is the result of having fewer deaths when compared with the expected 
number of deaths based on external rates. Reduction of the all-cause mortality rate 
by the all-cause SMR increases the 𝑆(𝑡), which prolongs survival and shifts deaths 
toward an older age. Unfortunately, the nonleukemia incidence (mortality) rate is 
greater at older ages, and therefore the lifetime risk of cancer incidence (mortality) 
increases with increased survival. Overall, the BLR based on ∫ 𝑆(𝑡)ℎ𝑐(𝑡)𝑑𝑡 is 
greater when 𝑆(𝑡) is adjusted by HWE and the all-cause SMR is less than unity.liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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their location 𝑎 and scale 𝑏 parameter values 
obtained from ECDF.
Cause of death Distribution
location, 𝑎 scale, 𝑏
All causes log-normal
𝑎 = −0.38014 𝑏 = 0.42032
Nonleukemia log-normal
𝑎 = −0.33716 𝑏 = 0.22020
Oral cavity log-normal
𝑎 = −0.30325 𝑏 = 0.82372
Digestive logistic
𝑎 = 0.47840 𝑏 = 0.11108
Esophagus gamma
𝑏 = 2.16876 𝑐 = 0.30933
Stomach log-normal
𝑎 = −0.38190 𝑏 = 0.30119
Colon log-normal
𝑎 = −0.14719 𝑏 = 0.20620
Rectum log-normal
𝑎 = −0.09490 𝑏 = 0.38529
Liver log-normal
𝑎 = −0.17627 𝑏 = 0.32532
Pancreas log-normal
𝑎 = −0.01986 𝑏 = 0.25942
Larynx log-normal
𝑎 = −0.27146 𝑏 = 0.42053
Lung logistic
𝑎 = 0.79975 𝑏 = 0.13287
Bone logistic
𝑎 = 0.71073 𝑏 = 0.25664
Prostate log-normal
𝑎 = 0.00527 𝑏 = 0.22997
Bladder log-normal
𝑎 = −0.22875 𝑏 = 0.21414
Kidney log-normal
𝑎 = −0.05823 𝑏 = 0.43994
CNS logistic
𝑎 = 0.94877 𝑏 = 0.28094
Thyroid log-normal
𝑎 = 0.14510 𝑏 = 0.34936
Leukemia logistic
𝑎 = 0.87669 𝑏 = 0.14132
Monte Carlo uncertainty analysis results for lifetime risks and eﬀects of 
correcting for the HWE, cancer-speciﬁc HWE, and cancer misclassiﬁcation are 
listed in tables providing all possible combinations of usage of correction factors. 
The primary outcome from Monte Carlo uncertainty analysis is a distribution of an 
estimate, based on an underlying model described in the form of an equation. 
A common approach for reﬂecting Monte Carlo uncertainty results is to report the 
lower, middle, and upper percentiles, for example, the 5th, median, and 95th, as 
indicators of the scale of the outcome. The Monte Carlo uncertainty analysis 
results provide these percentiles for the various models used. Fig. 7 reﬂects the 
uncertainties in ELR of mortality for all cancers except leukemia (“nonleukemia”) liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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Table 5. Cancer mortality co√
𝑝𝑞∕𝑛, where 𝑝 is the rate, 𝑞
Cancer Dea
certiﬁ
All cancers 1230
Oral cavity 19
Esophagus 50
Stomach 444
Colon 43
Rectum 45
Liver 42
Gall bladder 42
Pancreas 56
Lung 192
Breast 40
Uterus 70
Cervix 16
Prostate 13
Kidney, Bladder 38
Lymphoma 40
Leukemia 42
* 𝜓 Exceeds unity for under-
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= 1 − 𝑝, and 𝑛 is the number in agreement.
th 
cate
Autopsy Agreement Conﬁrmation 
rate, 𝜽
Detection 
rate, 𝝓
Ratio*
𝝍 = 𝜽∕𝝓
1692 929 0.755(0.014) 0.549(0.016) 1.376(0.022)
17 13 0.684(0.129) 0.765(0.118) 0.895(0.175)
53 36 0.72(0.075) 0.679(0.078) 1.06(0.108)
495 374 0.842(0.019) 0.756(0.022) 1.115(0.029)
54 28 0.651(0.09) 0.519(0.094) 1.256(0.13)
46 32 0.711(0.08) 0.696(0.081) 1.022(0.114)
169 26 0.619(0.095) 0.154(0.071) 4.024(0.119)
169 26 0.619(0.095) 0.154(0.071) 4.024(0.119)
81 36 0.643(0.08) 0.444(0.083) 1.446(0.115)
172 117 0.609(0.045) 0.68(0.043) 0.896(0.062)
49 38 0.95(0.035) 0.776(0.068) 1.225(0.076)
83 57 0.814(0.052) 0.687(0.061) 1.186(0.08)
64 14 0.875(0.088) 0.219(0.11) 4(0.141)
24 5 0.385(0.218) 0.208(0.182) 1.846(0.283)
60 30 0.789(0.074) 0.5(0.091) 1.579(0.118)
56 31 0.775(0.075) 0.554(0.089) 1.4(0.117)
40 36 0.857(0.058) 0.9(0.05) 0.952(0.077)
reported cancers, whereas is less than unity for over-reported cancers.
Figure 6. Concept of correcting 𝑆(𝑡) for HWE by applying an all-cause SMR of 0.68 (exp(-0.38)) to 
all-cause death rate, ℎ(𝑡), when estimating survivorship function, 𝑆(𝑡), for baseline lifetime risk (BLR) 
calculation. Values of 𝑆(𝑡) at attained age 𝑡 = 100 without and with correction for HWE were 𝑆(100) =
0.016 and 𝑆(100) = 0.288, respectively. The integral product ∫ 𝑆(𝑡)ℎ𝑐(𝑡)𝑑𝑡 based on the rate ℎ𝑐(𝑡) for 
nonleukemia (all cancers less leukemia) was 0.526 without HWE correction and 0.816 with correction for 
HWE. Therefore, the mean change in BLR for nonleukemia was 0.29 = 0.816–0.526. (Note: the cancer 
rate for the 85+ group is applied to all ages above 85).
for males and females exposed to 1 Sv at age 35 for the EAR, ERR(EAR), ERR, 
and mixture models (latency and DDREF quantiles applied) with and without 
adjustment by combinations of all-cause SMR values (“AC”), all cancers SMR 
(“CA”), and all-cancers misclassiﬁcation (“MC”). Fig. 8 reﬂects the uncertainties 
in ELR of male and female nonleukemia incidence for exposure to 1 Sv at age 35 
for the EAR, ERR(EAR), ERR, and mixture models (latency and DDREF quantiles 
applied) with and without adjustment by combinations of all-cause SMR values 
(“AC”) and all-cancers SMR (“CA”). Fig. 9 reﬂects the uncertainties in ELR of liyon.2015.e00048
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(http://creativecommons.org/licenses/Figure 7.Uncertainties in excess lifetime risk (ELR) of radiation-induced cancer (nonleukemia) mortality 
for males and females exposed to 1 Sv at age 35 for the EAR, ERR(EAR), ERR, and mixture models 
(latency and DDREF quantiles applied) with and without adjustment by combinations of all-cause 
SMR values (“AC”), all-cancer SMRs (“CA”), and misclassiﬁcation of cancer (“MC”). 10,000 life table 
calculations performed.
male and female leukemia mortality for exposure to 1 Sv at age 35 for the EAR, 
ERR(EAR), ERR, and mixture models (latency and DDREF quantiles applied) 
with and without adjustment by combinations of all-cause SMR (“AC”), leukemia 
SMR (“CA”), and leukemia misclassiﬁcation (“MC”). Fig. 10 reﬂects the 
uncertainties in ELR of male and female leukemia incidence for exposure to 1 Sv at 
age 35 for the EAR, ERR(EAR), ERR, and mixture models (latency and DDREF 
quantiles applied) with and without adjustment by combinations of all-cause SMR 
values (“AC”) and leukemia SMR (“CA”). Table 6 lists ELR, PC, and BLR of 
cancer mortality risks for nonleukemia projected for US males and females 
exposed to 1 Sv at age 35 adjusted for all-cause SMR, SMR for all cancers, and 
misclassiﬁcation. Table 7 lists ELR, PC, and BLR of cancer incidence risks for 
nonleukemia incidence projected for US males and females exposed to 1 Sv at age 
35 adjusted for all-cause SMR, and SMR for all cancers. Table 8 lists ELR, PC, and 
BLR of leukemia mortality risks projected for US males and females exposed to 
1 Sv at age 35 adjusted for all-cause SMR, SMR for leukemia, and 
misclassiﬁcation. Table 9 lists ELR, PC, and BLR of leukemia incidence risks 
projected for US males and females exposed to 1 Sv at age 35 adjusted for all-cause 
SMR and SMR for leukemia.liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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for males and females exposed to 1 Sv at age 35 for the EAR, ERR(EAR), ERR, and mixture models 
(latency and DDREF quantiles applied) with and without adjustment by combinations of all-cause SMR 
values (“AC”), and all-cancer SMRs (“CA”). 10,000 life table calculations performed.
Lastly, results of multiple linear regression of lifetime risks on binary (yes/no) 
indicator variables representing the corrections made are provided in the remaining 
tables. The regression coeﬃcients allowed us to get a handle on the mean 
diﬀerence in lifetime risk due to each adjustment. Table 10 lists regression 
coeﬃcients (z-score) reﬂecting the mean change (%) in ELR of cancer mortality for 
various adjustments. Table 11 lists regression coeﬃcients (z-score) reﬂecting the 
mean change (%) in PC of cancer mortality for various adjustments. Table 12 lists 
regression coeﬃcients (z-score) reﬂecting the mean change (%) in BLR of cancer 
mortality for various adjustments. Table 13 lists regression coeﬃcients (z-score) 
reﬂecting the mean change (%) in ELR of cancer incidence for various adjustments. 
Table 14 lists regression coeﬃcients (z-score) reﬂecting the mean change (%) in PC 
of cancer incidence for various adjustments. Table 15 lists regression coeﬃcients 
(z-score) reﬂecting the mean change (%) in BLR of cancer incidence for various 
adjustments. For all cancers combined (nonleukemia), the eﬀect of adjusting the 
all-cause hazard rate by the simulated quantiles of the all-cause SMR resulted in a 
mean diﬀerence (not percent diﬀerence) of 0.65% for ELR and 4% for BLR of 
mortality, and mean diﬀerence of 6.2% in BLR for incidence. The eﬀect of 
adjusting the excess radiation-induced cancer rate or baseline cancer rate by 
simulated quantiles of cancer-speciﬁc SMRs resulted in a mean diﬀerence of 
−1.2% in all-cancer mortality ELR and −6.4% in the all-cancer mortality BLR. liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
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and females exposed to 1 Sv at age 35 for the EAR, ERR(EAR), ERR, and mixture models (latency 
and DDREF quantiles applied) with and without adjustment by combinations of all-cause SMR values 
(“AC”), leukemia SMRs (“CA”), and misclassiﬁcation of cancer (“MC”). 10,000 life table calculations 
performed.
Whereas for incidence, the eﬀect of adjusting by cancer-speciﬁc SMRs resulted in a 
mean diﬀerence of −14.4% in the all-cancer BLR. Correction for cancer mortality 
misclassiﬁcation resulted in a mean diﬀerence of 4% for the PC of nonleukemia.
4. Discussion
This report presents original results from Poisson regression of LSS data, and 
presents results of novel applications of Monte Carlo uncertainty analysis for 
projection of lifetime risks of exposure to ionizing radiation. No ﬁxed values were 
used as inputs into the life tables that were generated, and instead simulated 
quantiles from distributions representing the various sources of input information 
were generated for each gender, organ, and risk model. Within life tables, all 1-year 
all-cause mortality and cancer mortality and incidence rates were simulated as well.
Many of the Poisson regression models resulted in residuals for which the overly 
inﬂuential observations could have been removed, and the model re-ﬁtted. 
However, we did not remove outliers because there is typically a very sparse 
number of events in each cross-tabulation cell in the LSS data. As an example, 
regarding the LSS cancer mortality data for solid cancers, 88.7% (47,692/53,782)
of the person-year cross-tabulation table cells (records) have zero deaths, while for liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
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and females exposed to 1 Sv at age 35 for the EAR, ERR(EAR), ERR, and mixture models (latency and 
DDREF quantiles applied) with and without adjustment by combinations of all-cause SMR values (“AC”) 
and leukemia SMRs (“CA”). 10,000 life table calculations performed.
LSS cancer incidence data (solid cancers), 73.8% (19,790/26,806) of the records 
have zero cases. Thus, for solid cancers, only 11–24% of the records have non-zero 
events. This results in very large standardized residuals in records with events and 
much smaller standardized residuals in records without events (most of the 
records). Since events are so rare in the LSS data tabulations, removing the largest 
outliers which mostly occur in records with events, will remove the 
desperately-needed events – ultimately sacriﬁcing the model. This runs contrary to 
“textbook”-type Poisson regression methods which have non-zero rates in the 
majority of records. Overall, the greatest residuals occur in records with events, 
and since events are rare, removal of these records would be deleterious on the 
model. The leverage residuals did not load as heavily on records with non-zero 
events, so leverages are likely more appropriate since they don’t present large 
imbalances in their values. Multicollinearity also did not seem to be an issue using 
the parameters determined. Additional evaluation of the regression diagnostics is 
required because of the voluminous output involved.
We believe that overlap of occupational studies may be a potential source of bias 
among the SMRs reported. None of the reports (SMRs) used were for the same 
study. Several studies were updates of previous investigations, or novel pooled 
studies of multiple cohorts, and therefore the published SMR values from those liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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Table 6. Excess lifetime risk
all cancers except leukemia (
SMR, SMR for all cancers, a
Gender Adjustment*
Males
M
M
M
M
CA
CA
CA
CA
CA M
CA M
CA M
CA M
AC
AC
AC
AC
AC M
AC M
AC M
AC M
AC CA
AC CA
AC CA
AC CA
AC CA M
AC CA M
AC CA M
AC CA M
Females
M
M
M
M
CA
CA
CA
CA
CA M
CA M
CA M
CA M
AC
AC
AC
AC
AC M
AC M
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Model ELR(95% CI) PC(95% CI) BLR(95% CI)
EAR 4.261(2.256, 7.931) 16.686(9.592, 27.167) 21.279(21.205, 21.351)
ERR(EAR) 4.475(2.425, 8.289) 17.377(10.234, 28.035) 21.277(21.209, 21.349)
ERR 2.641(1.291, 5.151) 11.045(5.724, 19.486) 21.278(21.208, 21.348)
MIX 3.770(1.648, 7.578) 15.055(7.194, 26.260) 21.278(21.207, 21.349)
C EAR 5.770(3.121, 10.520) 21.331(12.785, 33.099) 21.279(21.206, 21.351)
C ERR(EAR) 6.085(3.277, 11.181) 22.242(13.349, 34.447) 21.278(21.207, 21.348)
C ERR 3.606(1.694, 6.851) 14.477(7.377, 24.367) 21.278(21.207, 21.349)
C MIX 5.099(2.227, 10.185) 19.330(9.476, 32.351) 21.278(21.207, 21.349)
EAR 3.045(1.450, 6.178) 16.717(9.661, 27.094) 15.125(10.421, 21.894)
ERR(EAR) 3.207(1.570, 6.540) 17.603(10.256, 28.450) 15.094(10.489, 21.764)
ERR 1.896(0.848, 4.069) 11.164(5.705, 19.542) 15.186(10.442, 21.974)
MIX 2.690(1.098, 5.916) 15.124(7.231, 26.422) 15.136(10.443, 21.878)
C EAR 4.183(2.056, 8.548) 21.647(12.897, 33.793) 15.119(10.499, 21.841)
C ERR(EAR) 4.445(2.142, 8.843) 22.620(13.271, 35.009) 15.219(10.574, 21.946)
C ERR 2.579(1.139, 5.495) 14.539(7.560, 24.865) 15.206(10.519, 21.911)
C MIX 3.691(1.493, 8.053) 19.573(9.530, 32.875) 15.188(10.525, 21.898)
EAR 5.215(2.462, 10.695) 16.501(9.485, 26.709) 27.126(16.603, 38.428)
ERR(EAR) 5.516(2.542, 11.335) 17.248(9.788, 27.978) 27.113(16.590, 38.427)
ERR 3.107(1.366, 6.572) 10.506(5.239, 18.717) 27.088(16.607, 38.432)
MIX 4.530(1.794, 10.168) 14.739(6.823, 25.954) 27.113(16.604, 38.432)
C EAR 7.037(3.364, 14.312) 20.897(12.307, 32.735) 27.204(16.879, 38.278)
C ERR(EAR) 7.429(3.556, 15.171) 21.832(12.851, 34.003) 27.215(16.884, 38.282)
C ERR 4.279(1.903, 8.909) 13.893(7.113, 23.836) 27.205(16.897, 38.291)
C MIX 6.156(2.481, 13.552) 18.930(9.074, 31.952) 27.208(16.888, 38.288)
EAR 3.844(1.662, 8.505) 16.728(9.496, 27.252) 19.359(10.711, 32.184)
ERR(EAR) 3.990(1.738, 8.887) 17.404(9.911, 28.176) 19.241(10.790, 31.995)
ERR 2.255(0.928, 5.068) 10.664(5.382, 18.766) 19.254(10.740, 31.804)
MIX 3.296(1.234, 7.947) 14.901(6.889, 26.211) 19.278(10.745, 32.007)
C EAR 5.193(2.264, 11.234) 21.432(12.556, 33.386) 19.163(10.751, 32.119)
C ERR(EAR) 5.414(2.362, 11.992) 22.264(13.125, 34.716) 19.125(10.779, 31.956)
C ERR 3.069(1.248, 7.064) 14.082(6.969, 24.244) 19.206(10.789, 32.017)
C MIX 4.483(1.664, 10.718) 19.304(9.011, 32.551) 19.159(10.778, 32.028)
EAR 5.514(3.224, 9.532) 23.338(15.104, 34.486) 18.108(18.045, 18.170)
ERR(EAR) 5.783(3.288, 9.829) 24.210(15.372, 35.168) 18.109(18.047, 18.171)
ERR 4.745(2.608, 8.422) 20.765(12.576, 31.750) 18.108(18.046, 18.170)
MIX 5.344(2.949, 9.368) 22.790(14.015, 34.118) 18.108(18.046, 18.170)
C EAR 7.449(4.321, 12.698) 29.157(19.270, 41.218) 18.107(18.046, 18.171)
C ERR(EAR) 7.765(4.462, 13.421) 30.010(19.764, 42.572) 18.109(18.047, 18.170)
C ERR 6.420(3.572, 11.496) 26.171(16.467, 38.827) 18.108(18.047, 18.171)
C MIX 7.199(4.000, 12.667) 28.446(18.093, 41.152) 18.108(18.047, 18.171)
EAR 4.001(2.036, 7.752) 23.636(15.201, 34.889) 12.847(8.946, 18.794)
ERR(EAR) 4.208(2.164, 7.990) 24.418(15.668, 35.886) 12.930(8.984, 18.699)
ERR 3.436(1.716, 6.835) 21.034(12.607, 32.219) 12.952(8.945, 18.731)
MIX 3.864(1.931, 7.628) 23.056(14.120, 34.571) 12.916(8.961, 18.744)
C EAR 5.411(2.840, 10.185) 29.497(19.513, 41.719) 12.935(8.995, 18.579)
C ERR(EAR) 5.604(2.952, 10.620) 30.332(20.146, 42.878) 12.926(9.043, 18.612)
C ERR 4.625(2.365, 9.135) 26.474(16.713, 38.916) 12.894(8.899, 18.628)
C MIX 5.208(2.651, 10.093) 28.774(18.352, 41.498) 12.919(8.980, 18.612)
EAR 6.441(3.447, 11.697) 23.088(14.622, 34.014) 21.729(15.374, 27.887)
ERR(EAR) 6.680(3.593, 12.252) 23.842(15.332, 35.099) 21.737(15.377, 27.889)
ERR 5.553(2.871, 10.458) 20.511(12.511, 31.727) 21.731(15.376, 27.880)
MIX 6.199(3.224, 11.513) 22.493(13.857, 33.879) 21.732(15.377, 27.883)
C EAR 8.571(4.669, 15.597) 28.791(18.878, 40.888) 21.686(15.399, 27.704)
C ERR(EAR) 8.988(4.874, 16.260) 29.567(19.479, 42.121) 21.698(15.389, 27.666)liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
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Table 6. (Continued)
Gender Adjustment*
AC M
AC M
AC CA
AC CA
AC CA
AC CA
AC CA M
AC CA M
AC CA M
AC CA M
* AC denotes random quanti
CA denotes random quanti
MC denotes random quant
Table 7. Excess lifetime risk
for all cancers except leukem
all-cause SMR and SMR for
Gender Adjustment*
Males
CA
CA
CA
CA
AC
AC
AC
AC
AC CA
AC CA
AC CA
AC CA
Females
CA
CA
CA
CA
AC
AC
AC
AC
AC CA
AC CA
AC CA
AC CA
* AC denotes random quanti
CA denotes random quanti
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(http://creativecommons.org/licenses/Model ELR(95% CI) PC(95% CI) BLR(95% CI)
C ERR 7.443(3.873, 13.839) 25.790(16.217, 37.998) 21.690(15.396, 27.706)
C MIX 8.310(4.363, 15.358) 28.053(17.904, 40.737) 21.693(15.396, 27.699)
EAR 4.615(2.245, 9.265) 23.361(14.841, 34.408) 15.218(9.289, 24.013)
ERR(EAR) 4.827(2.400, 9.939) 24.226(15.510, 35.441) 15.188(9.240, 24.251)
ERR 4.001(1.869, 8.162) 20.743(12.564, 32.088) 15.238(9.256, 24.369)
MIX 4.470(2.127, 9.172) 22.765(13.989, 34.237) 15.216(9.264, 24.204)
C EAR 6.331(3.119, 12.756) 29.357(19.152, 41.821) 15.364(9.520, 24.031)
C ERR(EAR) 6.524(3.226, 12.944) 29.984(19.953, 42.562) 15.276(9.447, 23.727)
C ERR 5.428(2.597, 10.889) 26.161(16.413, 38.947) 15.398(9.455, 24.062)
C MIX 6.080(2.928, 12.308) 28.562(18.178, 41.354) 15.346(9.484, 23.940)
les of all-cause mortality SMR applied to life table all-cause hazard function, ℎ(𝑡).
les of all-cancers SMR applied to excess risk hazard function, ℎ𝑐 (𝑑, 𝑎, 𝑡).
iles of correction for cancer misclassiﬁcation applied to excess risk hazard function, ℎ𝑐 (𝑑, 𝑎, 𝑡).
 (ELR), probability of causation (PC), and baseline lifetime risk (BLR) of cancer incidence risks 
ia (nonleukemia) projected for US males and females exposed to 1 Sv at age 35 adjusted for 
 all cancers. Results in each row based on 10,000 Monte Carlo realizations of life tables.
Model ELR(95% CI) PC(95% CI) BLR(95% CI)
EAR 8.508(4.781, 14.927) 14.441(8.663, 22.850) 50.389(50.287, 50.493)
ERR(EAR) 8.910(5.002, 15.427) 15.023(9.032, 23.433) 50.390(50.286, 50.496)
ERR 8.552(4.648, 15.316) 14.507(8.445, 23.313) 50.390(50.286, 50.493)
MIX 8.646(4.802, 15.232) 14.649(8.701, 23.218) 50.389(50.286, 50.494)
EAR 6.305(3.195, 12.050) 14.861(8.909, 23.374) 36.096(24.920, 52.018)
ERR(EAR) 6.510(3.287, 12.561) 15.234(9.232, 24.295) 35.738(24.911, 51.924)
ERR 6.185(3.086, 12.376) 14.673(8.584, 23.566) 35.926(24.856, 52.113)
MIX 6.335(3.182, 12.305) 14.930(8.878, 23.743) 35.923(24.898, 52.019)
EAR 10.322(5.245, 19.895) 14.757(8.815, 23.489) 60.302(43.042, 77.064)
ERR(EAR) 10.837(5.494, 20.883) 15.427(9.115, 24.294) 60.302(43.011, 77.107)
ERR 9.564(5.042, 17.601) 13.970(8.021, 22.740) 60.308(43.031, 77.117)
MIX 10.198(5.239, 19.622) 14.714(8.606, 23.648) 60.303(43.031, 77.093)
EAR 7.595(3.517, 15.883) 15.069(8.958, 23.893) 42.846(26.403, 67.531)
ERR(EAR) 7.927(3.678, 16.821) 15.787(9.360, 25.145) 42.755(26.156, 67.452)
ERR 7.001(3.344, 14.198) 14.117(8.129, 22.922) 42.648(26.139, 67.850)
MIX 7.509(3.497, 15.712) 15.000(8.713, 24.062) 42.747(26.208, 67.634)
EAR 10.241(6.107, 17.386) 18.790(12.134, 28.212) 44.255(44.160, 44.347)
ERR(EAR) 10.534(6.195, 17.763) 19.226(12.292, 28.629) 44.254(44.162, 44.347)
ERR 14.328(8.312, 24.494) 24.454(15.812, 35.637) 44.253(44.162, 44.346)
MIX 11.506(6.491, 21.036) 20.637(12.788, 32.228) 44.254(44.161, 44.347)
EAR 7.592(3.948, 14.138) 19.294(12.279, 28.828) 31.529(21.768, 45.814)
ERR(EAR) 7.666(4.115, 14.483) 19.553(12.488, 29.312) 31.641(21.885, 45.566)
ERR 10.501(5.565, 19.725) 25.003(16.185, 36.516) 31.518(21.894, 45.401)
MIX 8.459(4.305, 16.753) 21.059(13.022, 32.873) 31.564(21.825, 45.591)
EAR 11.622(6.523, 20.214) 19.055(12.038, 28.247) 50.042(39.461, 59.387)
ERR(EAR) 11.792(6.628, 20.882) 19.235(12.288, 28.794) 50.043(39.475, 59.400)
ERR 15.315(8.844, 26.672) 23.676(15.274, 34.761) 50.046(39.460, 59.413)
MIX 12.834(7.009, 23.458) 20.530(12.807, 31.623) 50.043(39.462, 59.403)
EAR 8.482(4.316, 16.598) 19.236(12.288, 28.765) 35.769(22.977, 54.215)
ERR(EAR) 8.751(4.427, 16.878) 19.783(12.423, 29.505) 35.629(23.089, 54.043)
ERR 11.611(6.005, 21.775) 24.525(15.740, 36.028) 35.745(23.197, 54.122)
MIX 9.520(4.667, 19.130) 21.047(12.985, 32.455) 35.710(23.092, 54.135)
les of all-cause mortality SMR applied to life table all-cause hazard function, ℎ(𝑡).
les of all-cancer SMR applied to excess risk hazard function, ℎ𝑐 (𝑑, 𝑎, 𝑡).liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
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Table 8. Excess lifetime risk
projected for US males and f
misclassiﬁcation. Results in 
Gender Adjustment
Males
CA
CA
CA
CA
CA
CA
CA
CA
AC
AC
AC
AC
AC
AC
AC
AC
AC CA
AC CA
AC CA
AC CA
AC CA
AC CA
AC CA
AC CA
Females
CA
CA
CA
CA
CA
CA
CA
CA
AC
AC
AC
AC
AC
AC
AC
AC
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2405-8440/© 2015 The Authors. Pub
(http://creativecommons.org/licenses/ (ELR), probability of causation (PC), and baseline lifetime risk (BLR) of leukemia mortality risks 
emales exposed to 1 Sv at age 35 adjusted for all-cause SMR, SMR for leukemia, and 
each row based on 10,000 Monte Carlo realizations of life tables.
* Model ELR(95% CI) PC(95% CI) BLR(95% CI)
EAR 0.857(0.478, 1.506) 46.465(32.611, 60.397) 0.987(0.972, 1.002)
ERR(EAR) 0.838(0.467, 1.473) 45.941(32.088, 59.839) 0.987(0.972, 1.002)
ERR 1.279(0.643, 2.399) 56.455(39.436, 70.847) 0.987(0.972, 1.002)
MIX 0.956(0.497, 1.948) 49.225(33.485, 66.367) 0.987(0.972, 1.002)
MC EAR 0.817(0.451, 1.459) 45.280(31.342, 59.737) 0.987(0.972, 1.002)
MC ERR(EAR) 0.803(0.439, 1.426) 44.885(30.768, 59.162) 0.987(0.972, 1.002)
MC ERR 1.212(0.610, 2.314) 55.097(38.185, 70.048) 0.987(0.972, 1.002)
MC MIX 0.913(0.470, 1.888) 48.035(32.186, 65.688) 0.987(0.972, 1.002)
EAR 0.731(0.314, 1.506) 46.525(32.895, 60.662) 0.863(0.450, 1.276)
ERR(EAR) 0.728(0.309, 1.493) 46.177(32.404, 60.379) 0.870(0.464, 1.284)
ERR 1.080(0.421, 2.334) 56.482(39.504, 70.692) 0.862(0.449, 1.276)
MIX 0.824(0.333, 1.875) 49.266(33.809, 66.553) 0.865(0.454, 1.279)
MC EAR 0.700(0.295, 1.455) 45.161(31.177, 59.700) 0.865(0.458, 1.288)
MC ERR(EAR) 0.682(0.293, 1.422) 44.957(30.753, 59.162) 0.862(0.453, 1.274)
MC ERR 1.029(0.412, 2.217) 55.209(38.573, 69.830) 0.865(0.458, 1.273)
MC MIX 0.781(0.315, 1.799) 47.981(32.316, 65.600) 0.864(0.456, 1.277)
EAR 0.918(0.504, 1.644) 42.230(27.166, 58.757) 1.296(0.742, 1.915)
ERR(EAR) 0.892(0.489, 1.613) 41.467(26.313, 58.405) 1.297(0.742, 1.912)
ERR 1.555(0.702, 3.209) 55.280(38.046, 69.762) 1.297(0.745, 1.912)
MIX 1.043(0.525, 2.488) 45.961(28.188, 65.804) 1.297(0.743, 1.913)
MC EAR 0.857(0.469, 1.564) 40.358(25.546, 57.691) 1.303(0.758, 1.903)
MC ERR(EAR) 0.849(0.462, 1.545) 39.991(25.595, 57.305) 1.303(0.759, 1.907)
MC ERR 1.474(0.676, 3.069) 53.714(36.652, 68.873) 1.304(0.756, 1.904)
MC MIX 0.986(0.494, 2.387) 44.378(26.975, 64.645) 1.303(0.759, 1.906)
EAR 0.792(0.338, 1.647) 41.841(27.207, 58.421) 1.111(0.498, 2.005)
ERR(EAR) 0.780(0.329, 1.593) 41.598(26.779, 58.198) 1.116(0.497, 1.989)
ERR 1.335(0.492, 3.125) 55.094(38.465, 70.235) 1.116(0.499, 1.990)
MIX 0.911(0.362, 2.370) 45.841(28.492, 65.467) 1.115(0.499, 1.997)
MC EAR 0.746(0.320, 1.552) 40.591(25.696, 57.937) 1.101(0.500, 1.997)
MC ERR(EAR) 0.733(0.301, 1.517) 40.154(25.370, 57.456) 1.102(0.482, 1.983)
MC ERR 1.260(0.457, 2.948) 53.774(36.418, 69.073) 1.106(0.487, 1.979)
MC MIX 0.854(0.336, 2.231) 44.426(27.066, 64.582) 1.103(0.492, 1.986)
EAR 0.555(0.311, 0.975) 44.363(30.928, 58.378) 0.695(0.683, 0.707)
ERR(EAR) 0.545(0.308, 0.964) 43.938(30.715, 58.119) 0.695(0.683, 0.707)
ERR 1.106(0.553, 2.080) 61.389(44.304, 74.949) 0.695(0.683, 0.707)
MIX 0.660(0.331, 1.645) 48.695(32.227, 70.318) 0.695(0.683, 0.707)
MC EAR 0.525(0.292, 0.941) 42.998(29.595, 57.517) 0.695(0.683, 0.707)
MC ERR(EAR) 0.522(0.286, 0.939) 42.853(29.210, 57.522) 0.695(0.683, 0.707)
MC ERR 1.057(0.515, 2.011) 60.315(42.563, 74.369) 0.695(0.683, 0.707)
MC MIX 0.627(0.308, 1.594) 47.443(30.726, 69.615) 0.695(0.683, 0.707)
EAR 0.471(0.201, 0.958) 44.260(30.727, 58.360) 0.607(0.323, 0.900)
ERR(EAR) 0.468(0.203, 0.953) 44.065(30.977, 57.935) 0.609(0.323, 0.888)
ERR 0.941(0.377, 2.027) 61.320(43.887, 74.920) 0.610(0.321, 0.903)
MIX 0.568(0.223, 1.559) 48.548(32.299, 70.439) 0.609(0.322, 0.898)
MC EAR 0.451(0.189, 0.926) 43.126(29.367, 57.523) 0.610(0.324, 0.901)
MC ERR(EAR) 0.443(0.189, 0.921) 42.640(28.954, 57.126) 0.612(0.326, 0.902)
MC ERR 0.892(0.352, 1.948) 60.153(42.748, 74.048) 0.606(0.328, 0.898)
MC MIX 0.542(0.210, 1.485) 47.346(30.718, 69.491) 0.609(0.326, 0.900)
EAR 0.584(0.324, 1.058) 40.804(26.853, 56.729) 0.866(0.568, 1.166)
ERR(EAR) 0.577(0.315, 1.028) 40.512(26.429, 56.076) 0.866(0.569, 1.167)
ERR 1.290(0.609, 2.597) 60.272(43.109, 74.205) 0.866(0.568, 1.167)
MIX 0.702(0.344, 2.003) 45.909(28.167, 69.795) 0.866(0.568, 1.167)
MC EAR 0.562(0.302, 0.994) 39.798(25.525, 55.502) 0.865(0.569, 1.158)
MC ERR(EAR) 0.553(0.298, 0.996) 39.479(25.306, 55.292) 0.864(0.569, 1.157)
MC ERR 1.228(0.568, 2.512) 59.210(41.563, 73.884) 0.865(0.570, 1.157)
MC MIX 0.673(0.323, 1.947) 44.757(26.999, 68.978) 0.865(0.569, 1.157)liyon.2015.e00048
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Table 8. (Continued)
Gender Adjustment
AC CA
AC CA
AC CA
AC CA
AC CA
AC CA
AC CA
AC CA
* AC denotes random quanti
CA denotes random quanti
MC denotes random quant
Table 9. Excess lifetime risk
projected for US males and f
each row based on 10,000 M
Gender Adjustment*
Males
CA
CA
CA
CA
AC
AC
AC
AC
AC CA
AC CA
AC CA
AC CA
Females
CA
CA
CA
CA
AC
AC
AC
AC
AC CA
AC CA
AC CA
AC CA
* AC denotes random quanti
CA denotes random quanti
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(http://creativecommons.org/licenses/* Model ELR(95% CI) PC(95% CI) BLR(95% CI)
EAR 0.509(0.214, 1.035) 41.138(27.072, 56.743) 0.737(0.343, 1.242)
ERR(EAR) 0.498(0.205, 1.023) 40.750(26.468, 56.445) 0.738(0.343, 1.234)
ERR 1.101(0.410, 2.448) 60.376(42.769, 74.202) 0.738(0.349, 1.237)
MIX 0.617(0.233, 1.850) 46.025(28.359, 69.608) 0.738(0.345, 1.238)
MC EAR 0.477(0.196, 0.995) 39.779(25.262, 55.610) 0.741(0.344, 1.242)
MC ERR(EAR) 0.469(0.196, 0.970) 39.178(25.115, 55.487) 0.740(0.353, 1.247)
MC ERR 1.057(0.386, 2.381) 59.424(41.634, 73.624) 0.743(0.353, 1.249)
MC MIX 0.582(0.219, 1.803) 44.667(26.850, 68.838) 0.742(0.350, 1.246)
les of all-cause mortality SMR applied to life table all-cause hazard function, ℎ(𝑡).
les of all-cancers SMR applied to excess risk hazard function, ℎ𝑐 (𝑑, 𝑎, 𝑡).
iles of correction for cancer misclassiﬁcation applied to excess risk hazard function, ℎ𝑐 (𝑑, 𝑎, 𝑡).
 (ELR), probability of causation (PC), and baseline lifetime risk (BLR) of leukemia incidence risks 
emales exposed to 1 Sv at age 35 adjusted for all-cause SMR and SMR for leukemia. Results in 
onte Carlo realizations of life tables.
Model ELR(95% CI) PC(95% CI) BLR(95% CI)
EAR 0.784(0.417, 1.366) 33.925(21.493, 47.241) 1.526(1.509, 1.544)
ERR(EAR) 0.756(0.401, 1.323) 33.127(20.821, 46.415) 1.526(1.508, 1.544)
ERR 2.400(1.203, 4.515) 61.128(44.104, 74.786) 1.526(1.508, 1.544)
MIX 0.961(0.446, 3.569) 38.642(22.626, 70.019) 1.526(1.508, 1.544)
EAR 0.667(0.280, 1.359) 33.859(21.755, 47.503) 1.346(0.714, 1.988)
ERR(EAR) 0.649(0.262, 1.324) 33.029(20.802, 46.712) 1.341(0.707, 1.983)
ERR 2.054(0.820, 4.356) 61.315(44.071, 74.560) 1.346(0.711, 1.972)
MIX 0.854(0.305, 3.344) 38.653(22.639, 69.986) 1.344(0.710, 1.982)
EAR 0.821(0.439, 1.445) 30.734(18.327, 45.020) 1.892(1.269, 2.536)
ERR(EAR) 0.793(0.421, 1.423) 29.915(17.786, 44.682) 1.890(1.265, 2.535)
ERR 2.727(1.318, 5.266) 59.622(42.208, 73.422) 1.890(1.268, 2.538)
MIX 1.017(0.466, 4.151) 35.767(19.434, 68.696) 1.890(1.268, 2.536)
EAR 0.705(0.291, 1.449) 30.621(18.626, 45.186) 1.627(0.775, 2.714)
ERR(EAR) 0.676(0.274, 1.384) 29.979(17.991, 44.519) 1.614(0.761, 2.733)
ERR 2.345(0.897, 5.134) 59.503(42.027, 73.713) 1.621(0.781, 2.704)
MIX 0.905(0.319, 3.882) 35.858(19.752, 68.799) 1.622(0.771, 2.715)
EAR 0.697(0.406, 1.202) 39.429(27.452, 52.897) 1.071(1.057, 1.086)
ERR(EAR) 0.686(0.387, 1.201) 39.020(26.563, 52.829) 1.072(1.057, 1.086)
ERR 2.586(1.341, 4.722) 70.719(55.617, 81.508) 1.072(1.057, 1.086)
MIX 0.870(0.427, 3.795) 44.802(28.471, 77.993) 1.072(1.057, 1.086)
EAR 0.597(0.254, 1.202) 39.460(27.051, 52.798) 0.940(0.493, 1.392)
ERR(EAR) 0.595(0.256, 1.185) 39.252(26.652, 52.839) 0.944(0.492, 1.384)
ERR 2.209(0.901, 4.565) 70.637(55.097, 81.554) 0.942(0.502, 1.391)
MIX 0.784(0.288, 3.534) 44.798(28.241, 77.860) 0.942(0.495, 1.389)
EAR 0.736(0.414, 1.281) 37.127(24.746, 51.249) 1.261(0.920, 1.581)
ERR(EAR) 0.732(0.405, 1.272) 37.099(24.549, 51.014) 1.261(0.921, 1.580)
ERR 2.847(1.418, 5.393) 69.669(53.963, 80.944) 1.261(0.921, 1.581)
MIX 0.921(0.440, 4.267) 42.694(25.952, 77.307) 1.261(0.921, 1.581)
EAR 0.633(0.267, 1.303) 37.281(24.561, 51.623) 1.084(0.533, 1.746)
ERR(EAR) 0.626(0.267, 1.294) 36.845(24.401, 51.380) 1.095(0.538, 1.767)
ERR 2.478(0.974, 5.306) 69.713(54.607, 80.796) 1.097(0.542, 1.760)
MIX 0.829(0.303, 4.021) 42.752(25.938, 77.262) 1.092(0.537, 1.760)
les of all-cause mortality SMR applied to life table all-cause hazard function, ℎ(𝑡).
les of all-cancers SMR applied to excess risk hazard function, ℎ𝑐 (𝑑, 𝑎, 𝑡).liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
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Table 10. Regression coeﬃc
various adjustments. ELR re
cancer SMRs, applying misc
Cancer Model
Nonleukemia EAR
ERR(EAR)
ERR
MIX
Esophagus EAR
ERR(EAR)
ERR
MIX
Lung EAR
ERR(EAR)
ERR
MIX
Stomach EAR
ERR(EAR)
ERR
MIX
Liver EAR
ERR(EAR)
ERR
MIX
Colon EAR
ERR(EAR)
ERR
MIX
Kidney ERR
Bladder EAR
ERR(EAR)
ERR
MIX
Leukemia EAR
ERR(EAR)
ERR
MIX
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(http://creativecommons.org/licenses/ients (z-score) reﬂecting the mean change (%) in excess lifetime risk (ELR) of cancer mortality for 
gressed on age at exposure and dummy indicator variables for applying all-cause SMR, applying 
lassiﬁcation corrections, and females.
Age at
exposure*10
All-cause
SMR
Cancer
SMR
Misclassiﬁcation Female
−1.277(−22.07) 0.759(8.04) −1.332(−14.11) 1.214(12.85) 1.167(12.36)
−1.402(−21.88) 0.832(7.95) −1.366(−13.05) 1.29(12.32) 1.168(11.16)
−1.208(−13.81) 0.483(3.39) −0.937(−6.57) 0.855(5.99) 1.388(9.72)
−1.299(−19.85) 0.65(6.08) −1.204(−11.26) 1.108(10.37) 1.283(12)
0.06(20.98) 0.019(3.99) −0.055(−11.78) 0.013(2.7) –
0.062(18.22) 0.024(4.27) −0.059(−10.62) 0.009(1.65) –
0.031(14.22) 0.01(2.88) −0.045(−12.49) 0.004(0.98) –
0.051(19.36) 0.018(4.1) −0.055(−12.64) 0.009(2.01) –
−0.241(−10.78) 0.265(7.26) −0.259(−7.09) −0.114(−3.12) 0.804(22.01)
−0.255(−10.92) 0.283(7.4) −0.271(−7.09) −0.127(−3.32) 0.868(22.72)
−0.073(−1.46) 0.298(3.62) −0.498(−6.05) −0.197(−2.4) 2.883(35.04)
−0.225(−8.22) 0.304(6.81) −0.308(−6.9) −0.136(−3.04) 1.258(28.18)
−0.076(−6.26) 0.116(5.83) −0.291(−14.69) 0.091(4.61) 0.593(29.92)
−0.078(−6.6) 0.12(6.21) −0.311(−16.07) 0.079(4.07) 0.611(31.58)
−0.022(−18.69) 0.009(4.68) −0.022(−11.32) 0.006(2.93) –
−0.088(−10.08) 0.09(6.3) −0.267(−18.79) 0.065(4.54) 0.286(20.12)
−0.59(−7.54) 0.388(3.04) −0.228(−1.78) 1.689(13.22) −0.412(−3.22)
−0.643(−7.99) 0.389(2.96) −0.252(−1.92) 1.801(13.71) −0.352(−2.68)
−0.091(−7.19) 0.044(2.16) −0.041(−1.98) 0.281(13.67) −0.119(−5.78)
−0.461(−8.01) 0.208(2.21) −0.199(−2.12) 1.16(12.35) −0.352(−3.75)
−0.099(−24.22) 0.037(5.48) −0.031(−4.69) 0.043(6.38) 0.053(7.92)
−0.108(−22.65) 0.037(4.71) −0.036(−4.69) 0.045(5.82) 0.048(6.18)
−0.105(−23.29) 0.029(4) −0.036(−4.93) 0.042(5.7) 0.109(14.79)
−0.103(−27.02) 0.034(5.52) −0.034(−5.48) 0.044(6.99) 0.067(10.75)
−0.01(−8.67) 0.002(1.28) −0.001(−0.75) 0.004(2.24) –
−0.035(−2.13) 0.14(5.24) −0.106(−3.98) 0.209(7.82) −0.227(−8.48)
−0.042(−2.32) 0.153(5.17) −0.115(−3.88) 0.234(7.92) −0.23(−7.8)
−0.085(−4.86) 0.144(5.05) −0.125(−4.4) 0.256(9) −0.35(−12.3)
−0.049(−2.85) 0.146(5.25) −0.115(−4.12) 0.228(8.21) −0.257(−9.26)
−0.075(−15.96) 0.047(6.11) −0.073(−9.54) −0.025(−3.32) −0.182(−23.82)
−0.071(−15.86) 0.045(6.16) −0.072(−9.74) −0.021(−2.89) −0.171(−23.18)
0.026(1.5) 0.227(8.01) −0.181(−6.41) −0.055(−1.94) 0.009(0.31)
−0.07(−12.27) 0.065(7.02) −0.083(−8.98) −0.029(−3.14) −0.183(−19.68)
studies were diﬀerent – helping us to establish the full range of uncertainty. While 
the Cardis et al. study [43] was a 15-country study, we don’t discount the value of 
SMRs reported by other studies, for which data were collected under separate 
circumstances and had diﬀerent random and systematic errors under play, which 
increases the value of these data in the context of replication. In addition, the 
meta-analysis results in Table 2 can overlap with other studies, however, few of the 
SMR values for the meta-analysis are the same as those reported by single studies.
Separate model ﬁts using ECDF were employed for the all-cause SMRs and 
each cancer-speciﬁc SMR. With regard to the identiﬁcation of SMRs, we wanted to 
sample as many SMRs as possible from the literature to develop the full spectrum 
of realizations. In doing so, the parametric models used to ﬁt (ECDF) SMRs 
resulted in smooth approximations of the uncertainty in SMR. When compared 
with all-cause SMRs, cancer-speciﬁc SMRs are more sensitive to the constellation liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
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Table 11. Regression coeﬃc
for various adjustments. PC r
cancer SMRs, applying misc
Cancer Model
Nonleukemia EAR
ERR(EAR)
ERR
MIX
Esophagus EAR
ERR(EAR)
ERR
MIX
Lung EAR
ERR(EAR)
ERR
MIX
Stomach EAR
ERR(EAR)
ERR
MIX
Liver EAR
ERR(EAR)
ERR
MIX
Colon EAR
ERR(EAR)
ERR
MIX
Kidney ERR
Bladder EAR
ERR(EAR)
ERR
MIX
Leukemia EAR
ERR(EAR)
ERR
MIX
38 http://dx.doi.org/10.1016/j.he
2405-8440/© 2015 The Authors. Pub
(http://creativecommons.org/licenses/ients (z-score) reﬂecting the mean change (%) in probability of causation (PC) for cancer mortality 
egressed on age at exposure and dummy indicator variables for applying all-cause SMR, applying 
lassiﬁcation corrections, and females.
Age at
exposure*10
All-cause
SMR
Cancer
SMR
Misclassiﬁcation Female
−4.54(−53.39) −0.005(−0.04) 0.167(1.2) 4.264(30.67) 7.233(52.04)
−4.77(−47.13) 0.023(0.14) 0.231(1.4) 4.386(26.54) 7.277(44.02)
−4.81(−17.06) −0.163(−0.35) 0.06(0.13) 3.41(7.41) 7.658(16.63)
−4.75(−36.33) −0.085(−0.4) 0.146(0.68) 3.979(18.64) 7.476(35.01)
10.29(25.3) −0.642(−0.97) 0.139(0.21) 1.263(1.9)
10.42(27.89) −0.707(−1.16) −0.158(−0.26) 1.149(1.88)
7.18(14.75) −1.432(−1.8) −0.075(−0.09) 0.732(0.92)
9.6(24.66) −0.84(−1.32) 0.095(0.15) 1.135(1.79)
−3.02(−14.06) 1.263(3.6) 0.112(0.32) −1.401(−4) 14.366(41)
−3.15(−14.37) 1.349(3.77) 0.15(0.42) −1.588(−4.44) 15.1(42.2)
−1.2(−3.31) −0.011(−0.02) 0.051(0.09) −1.593(−2.69) 34.086(57.65)
−2.74(−12.06) 1.203(3.24) 0.059(0.16) −1.555(−4.19) 19.324(52.03)
−1.94(−10.38) −1.103(−3.62) 0.226(0.74) 2.078(6.82) 26.16(85.85)
−2.2(−9.47) −0.795(−2.09) −0.525(−1.38) 1.801(4.74) 26.442(69.64)
−5.24(−57.32) −0.153(−1.03) −0.138(−0.92) 1.511(10.13)
−2.72(−20.22) −1.077(−4.9) −0.095(−0.43) 2.112(9.61) 20.783(94.57)
−9.15(−11.29) 2.399(1.81) −0.109(−0.08) 28.137(21.26) 8.529(6.44)
−8.94(−10.97) 2.257(1.7) 0.335(0.25) 27.895(20.96) 9.235(6.94)
−8.27(−10.77) 1.132(0.9) 0.334(0.27) 25.415(20.27) 5.414(4.32)
−11.84(−13.47) 2.418(1.68) −0.091(−0.06) 30.361(21.15) 7.028(4.9)
−4.92(−31.56) −0.253(−0.99) 0.055(0.22) 1.965(7.71) 3.476(13.64)
−5.23(−29.83) −0.35(−1.22) −0.151(−0.53) 2.148(7.5) 3.315(11.57)
−5.08(−30.3) −0.785(−2.86) −0.074(−0.27) 1.995(7.28) 6.141(22.42)
−5.04(−36.32) −0.443(−1.96) −0.081(−0.36) 2.06(9.1) 4.204(18.56)
−1.6(−9.23) 0.124(0.44) 0.122(0.43) 0.697(2.46)
−2.36(−9.23) 1.502(0.44) −0.045(0.43) 10.758(2.46)
−2.43(−3.59) 1.854(1.4) 0.027(−0.04) 10.987(10.01) 9.591(8.4)
−4.21(−3.5) 0.538(1.64) 0.07(0.02) 11.025(9.69) 5.293(8.46)
−2.81(−7.69) 1.37(0.6) −0.037(0.08) 10.872(12.32) 8.293(5.92)
−3.49(−4.44) −3.026(1.32) 0.181(−0.04) −1.341(10.51) 0.414(8.02)
−3.46(−21.6) −2.816(−11.46) 0.273(0.69) −1.17(−5.08) 0.559(1.57)
0.44(−22.02) −0.844(−10.98) −0.031(1.07) −1.265(−4.56) 9.669(2.18)
−2.86(1.22) −2.427(−1.44) 0.09(−0.05) −1.25(−2.16) 1.719(16.47)
of risk factors to which workers were exposed, and may or may not be elevated as a 
result of culture, risk-taking, and/or exposure to other cancer-related agents in the 
workplace. It is our belief that cancer-speciﬁc SMRs are merely a snapshot of the 
observed to expected ratio for the given cancer, and are less relevant to the HWE –
which is hinged to the all-cause SMR.
Other important factors aﬀecting the SMR include the age distribution of 
workers, length of follow-up, time since hire, and time since the end of 
employment. Unfortunately, the SMR is a statistic that is only based on observed 
and expected counts, so it is impossible to adjust SMRs by other covariates – since 
SMR analysis is not regression modeling which can control for other factors. 
Taking the above factors into consideration during selection and identiﬁcation of 
SMRs used in our risk projection methods would result in partitioning and 
parameterization of SMRs. This would reduce the number of SMR values available liyon.2015.e00048
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Table 12. Regression coeﬃc
for various adjustments. BLR
applying cancer SMRs, apply
Cancer Model
Nonleukemia EAR
ERR(EAR)
ERR
MIX
Esophagus EAR
ERR(EAR)
ERR
MIX
Lung EAR
ERR(EAR)
ERR
MIX
Stomach EAR
ERR(EAR)
ERR
MIX
Liver EAR
ERR(EAR)
ERR
MIX
Colon EAR
ERR(EAR)
ERR
MIX
Kidney ERR
Bladder EAR
ERR(EAR)
ERR
MIX
Leukemia EAR
ERR(EAR)
ERR
MIX
39 http://dx.doi.org/10.1016/j.he
2405-8440/© 2015 The Authors. Pub
(http://creativecommons.org/licenses/ients (z-score) reﬂecting the mean change (%) in baseline lifetime risk (BLR) of cancer mortality 
 regressed on age at exposure and dummy indicator variables for applying all-cause SMR, 
ing misclassiﬁcation corrections, and females.
Age at
exposure*10
All-cause
SMR
Cancer
SMR
Misclassiﬁcation Female
−0.085(−0.62) 3.964(17.74) −6.405(−28.67) 0.039(0.17) −4.027(−18.02)
−0.098(−0.7) 3.963(17.37) −6.437(−28.21) 0.082(0.36) −4.008(−17.56)
−0.037(−0.27) 3.992(17.86) −6.42(−28.72) 0.038(0.17) −4.06(−18.16)
−0.073(−0.54) 3.975(17.78) −6.418(−28.71) 0.054(0.24) −4.031(−18.03)
−0.012(−4.89) 0.033(8.09) −0.048(−11.85) 0.004(1.05)
−0.011(−5.21) 0.036(10.22) −0.051(−14.4) 0(−0.12)
−0.011(−5.12) 0.036(9.83) −0.05(−13.69) −0.001(−0.18)
−0.012(−5.21) 0.035(9.6) −0.049(−13.72) 0.001(0.3)
0.027(0.67) 0.997(14.88) −1.346(−20.08) 0.002(0.03) −1.886(−28.15)
0.037(0.9) 0.998(14.93) −1.345(−20.12) 0.012(0.19) −1.877(−28.09)
0.019(0.46) 0.984(14.17) −1.362(−19.63) 0.008(0.12) −1.851(−26.67)
0.027(0.67) 0.992(14.75) −1.352(−20.1) 0.01(0.15) −1.872(−27.83)
−0.005(−1.25) 0.08(11.71) −0.14(−20.56) 0.001(0.15) −0.159(−23.31)
−0.005(−1.39) 0.081(12.6) −0.138(−21.65) 0.003(0.4) −0.162(−25.3)
−0.006(−2.76) 0.057(16.89) −0.111(−32.99) 0(0.1)
−0.005(−1.34) 0.08(12.24) −0.14(−21.3) 0.002(0.23) −0.161(−24.53)
−0.005(−1.09) 0.089(11.03) −0.095(−11.81) 0.001(0.14) −0.455(−56.26)
−0.007(−1.35) 0.086(10.35) −0.096(−11.58) 0.002(0.2) −0.451(−54.14)
−0.006(−1.14) 0.085(10.61) −0.095(−11.86) 0(0.05) −0.453(−56.49)
−0.006(−1.22) 0.087(10.71) −0.096(−11.8) 0.001(0.14) −0.453(−55.85)
−0.004(−0.64) 0.381(38.02) −0.251(−25.08) 0.007(0.74) −0.135(−13.44)
−0.005(−0.88) 0.382(41.29) −0.247(−26.75) 0.005(0.51) −0.138(−14.97)
−0.004(−0.72) 0.383(39.63) −0.249(−25.8) 0.003(0.35) −0.133(−13.77)
−0.004(−0.75) 0.382(40.48) −0.249(−26.35) 0.005(0.57) −0.135(−13.77)
−0.001(−0.29) 0.134(28.68) −0.144(−30.93) 0(0.04)
−0.012(−0.91) 0.194(8.9) −0.154(−7.06) 0.001(0.06)
−0.012(−0.89) 0.195(8.92) −0.154(−7.05) 0.002(0.09) −0.578(−26.63)
−0.012(−0.88) 0.193(8.82) −0.154(−7.04) 0.002(0.11) −0.579(−26.44)
−0.012(−0.9) 0.194(8.91) −0.154(−7.07) 0.002(0.09) −0.579(−26.52)
0.002(0.26) 0.217(18.16) −0.135(−11.31) 0.006(0.46) −0.352(−26.6)
0.002(0.25) 0.217(18.29) −0.135(−11.36) 0.003(0.28) −0.348(−29.45)
0(0) 0.21(17.56) −0.135(−11.3) 0.003(0.27) −0.347(−29.3)
0.002(0.21) 0.215(18.16) −0.135(−11.44) 0.004(0.37) −0.349(−29.01)
for ECDF within each combination of factor levels. The strength of the Monte 
Carlo approach employed is hinged to the idea that the full range of observable 
SMRs are taken into account. As long as we are realizing all possible values of 
SMRs (for which there is indeed a bulk of the data near a central estimate), we are 
capturing the majority of data which exists.
It is also likely that the HWE among astronauts was underestimated. SMRs 
resulting from radiation exposed aviators and nuclear workers will be aﬀected by 
radiation-induced cancer risks, and may not be amenable for use when establishing 
baseline risks. While the all-cause SMR among astronauts has historically been 
lower than most aviator and nuclear worker study all-cause SMRs, it was reported 
[24] that in the LSAH, the use of an internal matched control population resulted in 
a cancer mortality SMR = 3.45 (95% CI, 0.66–7.56). This may explain a 3-fold 
diﬀerence in the baseline rate of cancer, which is not discernible with SMRs. liyon.2015.e00048
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
by-nc-nd/4.0/).
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(http://creativecommons.org/licenses/Table 13. Regression coeﬃcients (z-score) reﬂecting the mean change (%) in excess lifetime risk 
(ELR) of cancer incidence for various adjustments. ELR regressed on age at exposure and dummy 
indicator variables for applying all-cause SMR, applying cancer SMRs, and females.
Cancer Model Age at
exposure*10
All-cause
SMR
Cancer
SMR
Female
Nonleukemia EAR −2.477(−20.52) 1.001(5.08) −1.979(−10.04) 1.135(5.76)
ERR(EAR) −2.554(−23.68) 1.018(5.78) −2.029(−11.52) 1.143(6.49)
ERR −2.581(−13.5) 0.727(2.33) −2.456(−7.87) 3.742(11.98)
MIX −2.523(−20.94) 0.969(4.93) −2.087(−10.61) 1.892(9.62)
Esophagus ERR −0.029(−3.35) 0.011(0.78) −0.029(−2.1) −0.145(−10.39)
Lung EAR −0.049(−1.63) 0.283(5.73) −0.409(−8.29) 0.978(19.82)
ERR(EAR) −0.08(−2.28) 0.317(5.55) −0.414(−7.25) 1.055(18.48)
ERR 0.135(1.52) 0.362(2.5) −0.978(−6.76) 4.251(29.37)
MIX −0.047(−1.21) 0.398(6.2) −0.475(−7.4) 1.507(23.48)
Stomach EAR −0.33(−12.82) 0.287(6.83) −0.597(−14.22) −0.265(−6.32)
ERR(EAR) −0.35(−12.84) 0.263(5.91) −0.613(−13.77) −0.293(−6.57)
ERR −0.026(−15.03) 0.012(4.13) −0.032(−11.16) 0.035(12.21)
MIX −0.309(−13.8) 0.161(4.41) −0.489(−13.36) −0.158(−4.32)
Liver EAR −0.211(−5.17) 0.099(1.48) −0.07(−1.05) −0.721(−10.83)
ERR(EAR) −0.219(−5.42) 0.091(1.37) −0.081(−1.22) −0.767(−11.62)
ERR −0.009(−0.64) 0.012(0.5) −0.024(−1.02) −0.11(−4.64)
MIX −0.144(−4.76) 0.047(0.95) −0.056(−1.14) −0.514(−10.44)
Colon EAR −1.085(−9.48) 0.472(2.53) −0.189(−1.01)
ERR(EAR) −1.149(−9.74) 0.489(2.54) −0.213(−1.11)
ERR −0.207(−7.03) 0.146(3.03) −0.192(−3.98) −0.759(−15.76)
MIX −0.471(−5.15) 0.207(1.38) −0.185(−1.24) −0.814(−5.45)
Rectum ERR −0.121(−11.24) 0.058(3.29) −0.1(−5.69)
Bladder EAR −0.125(−4.18) 0.164(3.37) −0.138(−2.83) 0.325(6.68)
ERR(EAR) −0.133(−3.83) 0.171(3.02) −0.146(−2.59) 0.372(6.58)
ERR −0.876(−5.89) 1.054(4.34) −1.449(−5.96) 7.576(31.17)
MIX −0.17(−3.95) 0.29(4.11) −0.19(−2.69) 0.389(5.52)
Leukemia EAR −0.025(−5.78) 0.051(7.24) −0.088(−12.56) −0.013(−1.85)
ERR(EAR) −0.019(−4.74) 0.047(6.98) −0.08(−11.94) −0.007(−1.08)
ERR 0.423(13.6) 0.388(7.64) −0.383(−7.55) 0.337(6.64)
MIX −0.014(−3.11) 0.068(9.1) −0.077(−10.33) −0.016(−2.1)
A major observation from this study is that if a worker population exhibits a low 
value for all-cause SMR, it simply means that the number of deaths is lower than 
the external population, and hence the workers will, on average, live longer. Living 
longer implies that being healthy results in longer survival. Longer survival implies 
a greater risk of cancer since cancer rates increase with age. This creates a dilemma 
within the LSAH regarding radiation risk assessment, since the greater cancer 
mortality caused by living longer may confound or mask any signal related to 
radiation-induced cancer mortality. As such, it would be propitious to perform 
dose-response modeling within the LSAH in order to compare modeled cancer 
mortality rates between diﬀerent dose groups. To our knowledge, the LSAH has 
not published cancer mortality results based on modeling low vs. high space 
radiation exposure groups. The accident-speciﬁc SMR for astronauts has also been 
signiﬁcantly greater than unity, but the overall all-cause SMR is typically low.
This manuscript is neither about the LSAH nor use of an internal control 
population for assessing HWE. Rather, our approach is one that implemented liyon.2015.e00048
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causation (PC) of cancer incidence for various adjustments. PC regressed on age at exposure and 
dummy indicator variables for applying all-cause SMR, applying cancer SMRs, and females.
Cancer Model Age at
exposure*10
All-cause
SMR
Cancer
SMR
Female
Nonleukemia EAR −4.078(−61.69) 0.31(2.87) 0.189(1.75) 4.163(38.56)
ERR(EAR) −4.211(−52.35) 0.257(1.96) 0.329(2.51) 4.192(31.91)
ERR −3.944(−25.7) −0.436(−1.74) 0.208(0.83) 8.688(34.66)
MIX −4.073(−54.47) 0.11(0.9) 0.26(2.13) 5.506(45.1)
Esophagus ERR −2.764(−4.28) −0.031(−0.03) 0.142(0.13) −16.02(−15.19)
Lung EAR −0.363(−2.04) 0.761(2.62) −0.053(−0.18) 13.139(45.27)
ERR(EAR) −0.586(−2.82) 0.806(2.37) −0.056(−0.16) 13.566(39.96)
ERR 1.007(6.95) −0.44(−1.86) 0.071(0.3) 31.915(134.94)
MIX −0.28(−1.65) 0.904(3.27) 0.009(0.03) 16.869(60.96)
Stomach EAR −3.848(−17.3) 0.257(0.71) 0.405(1.11) 8.565(23.59)
ERR(EAR) −3.897(−15.69) −0.044(−0.11) 0.195(0.48) 8.036(19.82)
ERR −2.887(−17.43) −0.218(−0.81) 0.043(0.16) 9.862(36.46)
MIX −5.944(−19.53) 0.013(0.03) 0.324(0.65) 10.182(20.49)
Liver EAR −11.583(−13.31) 2.454(1.73) 0.418(0.29) −32.555(−22.91)
ERR(EAR) −12.182(−12.49) 1.459(0.92) −0.609(−0.38) −32.995(−20.71)
ERR 2.866(1.61) −0.058(−0.02) 0.15(0.05) 2.319(0.8)
MIX −8.216(−12.15) 1.067(0.97) 0.018(0.02) −27.144(−24.58)
Colon EAR −15.569(−22.63) 2.777(2.47) 0.094(0.08)
ERR(EAR) −15.95(−23.99) 2.548(2.35) 0.19(0.17)
ERR −3.42(−12.65) −0.523(−1.18) 0.072(0.16) −12.068(−27.34)
MIX −7.481(−6.32) 0.363(0.19) 0.164(0.08) −11.587(−6)
Rectum ERR −7.564(−25.88) 1.986(4.16) −0.197(−0.41)
Bladder EAR −0.633(−2.38) 0.751(1.73) 0.009(0.02) 3.154(7.27)
ERR(EAR) −0.641(−2.09) 0.776(1.55) 0.076(0.15) 3.511(6.99)
ERR −2.603(−3.19) 0.865(0.65) 0.49(0.37) 28.606(21.45)
MIX −0.748(−2.03) 1.21(2.01) 0.02(0.03) 3.616(6)
Leukemia EAR −0.42(−2.93) −1.894(−8.08) 0.084(0.36) 7.707(32.88)
ERR(EAR) −0.341(−2.69) −1.698(−8.22) 0.125(0.61) 7.874(38.12)
ERR 3.765(19.05) −0.834(−2.59) 0.288(0.89) 11.04(34.21)
MIX 0(0) −1.742(−9.71) 0.123(0.69) 8.233(45.87)
numerous realizations of SMRs for aviators and radiation workers to assess the 
eﬀect of adjusting lifetime risks through the use of SMRs. We also make no 
assumption that the present measures of astronaut HWE will remain in eﬀect 
during the decades to follow, when lifetime risks for long-term (90–120 day 
missions) exposures on International Space Station will be realized, or when 
lifetime risk is realized for Mars missions. The additional uncertainties surrounding 
radioepidemiologic investigation of human space workers exposed to high-energy 
ions (GCRs) is unknown, and therefore risks can be greater than assumed. Hence, 
the higher SMRs among astronauts in the LSAH may not be inadmissible. Readers 
need to recognize that under the Central Limit Theorem, an SMR value determined 
from a single worker study is merely a point estimate derived from a distribution 
centered at SMR = 1. If each of the SMR studies used in this investigation were 
replicated, then the resulting distribution of SMRs would be diﬀerent from those 
presented. Our investigation attempted to address the eﬀects of study replication by 
using the majority of published SMR values for aviator and nuclear worker studies, liyon.2015.e00048
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of cancer incidence for various adjustments. BLR regressed on age at exposure and dummy 
indicator variables for applying all-cause SMR, applying cancer SMRs, and females.
Cancer Model Age at
exposure*10
All-cause
SMR
Cancer
SMR
Female
Nonleukemia EAR −1.322(−3.14) 6.089(8.84) −14.318(−20.8) −8.539(−12.4)
ERR(EAR) −1.327(−3.16) 6.198(9.03) −14.492(−21.1) −8.522(−12.41)
ERR −1.368(−3.47) 6.396(9.93) −14.317(−22.23) −8.453(−13.12)
MIX −1.328(−3.22) 6.223(9.25) −14.383(−21.38) −8.523(−12.67)
Esophagus ERR −0.003(−0.14) 0.064(1.85) −0.132(−3.81) −0.784(−22.66)
Lung EAR −0.003(−0.04) 1.121(9.74) −1.768(−15.36) −2.175(−18.9)
ERR(EAR) −0.025(−0.35) 1.119(9.63) −1.757(−15.11) −2.135(−18.36)
ERR −0.002(−0.02) 1.146(9.91) −1.767(−15.29) −2.128(−18.41)
MIX −0.009(−0.13) 1.129(9.87) −1.764(−15.41) −2.147(−18.76)
Stomach EAR −0.014(−1.03) 0.124(5.76) −0.267(−12.43) −0.39(−18.14)
ERR(EAR) −0.013(−1) 0.124(5.65) −0.265(−12.08) −0.387(−17.69)
ERR −0.016(−1.27) 0.122(5.79) −0.263(−12.47) −0.391(−18.53)
MIX −0.014(−1.09) 0.124(5.8) −0.264(−12.4) −0.39(−18.28)
Liver EAR −0.016(−1.48) 0.089(4.93) −0.12(−6.64) −0.651(−36.16)
ERR(EAR) −0.016(−1.41) 0.082(4.49) −0.12(−6.58) −0.652(−35.76)
ERR −0.018(−1.72) 0.083(4.9) −0.116(−6.85) −0.656(−38.74)
MIX −0.017(−1.53) 0.085(4.78) −0.119(−6.69) −0.653(−36.87)
Colon EAR −0.052(−2.64) 0.681(21.06) −0.519(−16.06)
ERR(EAR) −0.034(−1.54) 0.701(19.53) −0.52(−14.5)
ERR −0.061(−1.25) 0.6(7.56) −0.843(−10.63) −0.408(−5.14)
MIX −0.058(−1.19) 0.603(7.5) −0.839(−10.44) −0.413(−5.14)
Rectum ERR −0.052(−5.72) 0.112(7.51) −0.325(−21.71)
Bladder EAR −0.481(−3.3) 1.375(5.77) −2.826(−11.86) −1.886(−7.91)
ERR(EAR) −0.484(−3.34) 1.374(5.8) −2.791(−11.78) −1.941(−8.19)
ERR −0.479(−3.35) 1.363(5.83) −2.814(−12.04) −1.941(−8.31)
MIX −0.48(−3.31) 1.367(5.78) −2.807(−11.87) −1.922(−8.12)
Leukemia EAR −0.032(−2.54) 0.238(11.45) −0.185(−8.92) −0.504(−24.24)
ERR(EAR) −0.029(−2.38) 0.236(11.69) −0.185(−9.17) −0.504(−24.96)
ERR −0.029(−2.41) 0.246(12.42) −0.181(−9.13) −0.514(−25.92)
MIX −0.031(−2.48) 0.24(11.94) −0.183(−9.12) −0.507(−25.25)
ﬁtting the SMRs with ECDF to develop smooth functions, and combining random 
quantiles from each source of information for input into 10,000 life table 
calculations, using diﬀerent random variates for each table. Because of random 
sampling of source information, it is highly unlikely that we used the same risk 
coeﬃcients, same radiation dose, same SMR, same misclassiﬁcation correction 
factor, same cancer rates and all-cause mortality rates in the life tables that were 
generated.
The results of excess and baseline lifetime risks are encapsulated in the form of 
an uncertainty distribution about some median value that represents the location, 
and 95% CIs representing the scale (or s.d.). There is no one single scalar value that 
can be used to determine if the eﬀect of HWE is underestimated or overestimated 
since the result is a distribution. Since lifetime risks of radiation-induced cancer are 
commonly presented in units of risk/Sv, we did not focus on historical or future 
dosimetry issues related to ﬂight (mission) planning in order to project risks for liyon.2015.e00048
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other results based on the standard units of risk/Sv.
Regarding ELRs, it is noteworthy to point out that the Risk of Exposure-Induced 
Death (REID) introduced by Thomas et al. [68] as
REID𝑐(𝑒,𝐷) = ∫
100
𝑒
[𝜇𝑐(𝑎|𝑒,𝐷) − 𝜇𝑐(𝑎)]𝑆(𝑎|𝑒,𝐷)𝑑𝑎 (57)
is equivalent to 𝜋(𝑎, 𝑑) because the hazard function 𝜇𝑐(𝑎|𝑒, 𝐷) − 𝜇𝑐(𝑎) subtracts out 
the hazard function for spontaneously occurring cancer. Thus, the hazard functions 
in Eqs. 6 and 7 of Thomas et al. would be stated in this report as
𝜇𝑐(𝑎, 𝑒, 𝑡, 𝑠, 𝑦,𝐷) = 𝛽(𝑎, 𝑒, 𝑡, 𝑠)𝑔(𝐷), (58)
for the additive projection model and
𝜇𝑐(𝑎, 𝑒, 𝑡, 𝑠, 𝑦,𝐷) = 𝜇(𝑎, 𝑦)𝛽(𝑎, 𝑒, 𝑡, 𝑠)𝑔(𝐷), (59)
for the multiplicative model. Our previous work [69] suggests that results of the 
Elandt-Johnson and Johnson [60] method of estimating lifetime risks have been 
found to be similar to those estimated by Bunger et al. [70] and Gail [71]. The only 
diﬀerence between the Elandt-Johnson and Johnson method and Bunger method is 
that the former is based on the integral product of a hazard function, ℎ𝑐(𝑑, 𝑎, 𝑡), and 
𝑆(𝑡) and the latter is based on the integral product of the conditional probability, 
𝑞(𝑡), and 𝑆(𝑡). Kahn and Sempos [72] suggest that the use of hazard rates will not 
underestimate risks based on probabilities because the denominator of a rate is 
comprised of fewer individuals (person-years) since it is based on the midpoint of 
the interval – probabilities, on the other hand, are based on denominator data at the 
beginning of the interval where the average person-years of follow-up is greater. 
Thus, the use of hazard rates in lifetime risk projection will result in estimates that 
are essentially slightly greater than risks based on probabilities.
Overall, the uncertainties surrounding lifetime risks of radiation exposure have 
always been complex, since workers are commonly exposed to mixtures of 
radiation from varying sources such as x- and 𝛾-ray, ﬁssion products, etc., with 
varying energies and varying dose and dose-rate. To date, the National Institutes of 
Health IREP report and computer algorithm provide the most comprehensive 
lifetime risk projections for varying type and energies of ionizing radiation [67, 
73]. To appropriately address ELRs for particulate space radiation, one needs to 
consider either a track-based or ﬂuence-based approach and couple the radiation 
environment models to the system for projecting ELRs [4]. The overall focus of 
this investigation was mainly devoted to simulation of SMRs and corrections for 
misclassiﬁcation, cancer and vital statistics, actuarial life table approaches, and 
how best to simulate uncertainty for all inputs used in lifetime risk projection.liyon.2015.e00048
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